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INTRODUCTION 
Most physicians are now seeing patients who have travelled in many parts of 
the world, and although the essentials of medical practice are the same in different 
global zones, some aspects of travel and tropical medicine are worthy of further 
consideration. This brief volume is not intended to bea complete guide to travel 
or tropical maladies, ~ut rather to serve as an -introduction to the s~bject, 
particularly as it concerns the general practitioner, and it is hciped that further 
reading on the subject will be encouraged. 
The concept of "Exotic" diseases is an important one and Maegraith 
defines these as being acquired outside the area in which the physician works. 
These notes are mainly confined to· subjects who· usually live outside the tropical 
zones, but who visit such areas in the course of their work or pleasure. It is 
pertinent to ask how common are imported tropical and parasitic diseases, but for 
most countries we have no exact figures. Reported cases of such diseases as amebic 
dysentery suggest that this malady is not a significant problem in such a country 
as Canada, but it would appear that many cases are not being diagnosed. The 
cases which are reported may well be the tip of the iceberg, particularly as some 
infections can remain asymptomatic, and the problem is more than an academic one 
as amebic infection may have a fatal outcome and amebic hepatic abscesses are 
often associated with much debility. 
The spectrum of tropical and parasitic diseases i~ a broad one and only a 
·few aspects of the problem are considered here. Thus a fair number of subjects 
consult their local family physician for advice on antimalarials and it is import-
ant for the physician to be aware of the different drugs used in the chemoprophy-
laxis of _malaria. Again diarrhea ranks high on the list of symptoms which patients 
bring to their_ physician on returning from the tropics and an approach to the pro-
blem is presented. As this is not ~ textbook of tropical diseases, only a handful 
of such conditions. are discussed and for further details it is essential that the 
practitioner turn to one of the excellent books covering this field. For in these 
days of stress, where psychosomatic disease reigns king, _it is very satisfying to 
identify a parasite and _then to be able to treat the patient, knowing that with 
·modern chemotherapy we can be sure of a cure in many instances. 
1. 
CHAPTER 1 
PREPARING FOR VISITS TO THE TROPICS. 
Personal Interview (?? Exclusions). 
Propaganda (Food/drink etc.). 
Prophylactic Immunizations. 
Prophylaxis Against Malaria. 
IS EVERYONE FIT TO TRAVEL TO THE TROPICS ?? 
The answer to this question is an emphatic no, but at the same time every 
case mu~t be assessed on its own merits, and any contraindications. to life in the 
tropics are usually relative ones rather than absolute exc-lusions. The following 
examples are merely quoted to give some idea of the extent of the problem. The 
tropics pose various physical and mental stresses to all subjects and in some in-
stances such an environment may be a real threat to the well-being of the individual. 
Thus the executive who is promised a plum post overseas may find that the increased 
mental and physical strains to.which he is subjected; become an overbearing problem 
to him. O'ne factor to always take into account is the duration of the visit, and 
neurasthenic states are not uncommon in the long stay visitor. The elderly should be 
warned to take life slowly in such areas, but in general tolerate the warmer climates 
fairly well. Subjects with a history of a significant mental disorder would be best 
advised to ke.ep away from tropical zones and in particular this applies to those with 
depression. Alcoholics often deteriorate rapidly where the normal social life in 
warmer regions encourages an exessive intake of alcohol. Life in the tropics tends 
to encourage the formation of renal calculi and if those with such a history must 
go, they should certainly watch their intake of fluids with .care. Obviously 1 ife 
in the larger towns and cities carries less risk than a rural existence for those 
with "un~table" diseases, and thus the ~iabetic should not wander too far off the 
beaten track.· Hepatitis is prevalent in these areas and those with a history of 
previous hepatitis should travel warily before exposing themselves again, and if 
it is imperative that they go then the use of gamma globulin is strongly 
recommended (as it is for ·a 11 visitors to these areas). ·Although the effect of 
sunlight is beneficial for some skin disorders, other dermatological conditions 
do not fare so well with this exposure, and fungal infections of. the skin, for· 
example, may flare up in hot humid climates. These same climatic factors also tend 
to upset some asthmatics, though a dry warm surrounding may ameliorate the condition 
of others with this illness. Subjects with certain gastrointestinal disorders should 
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avoid the tropics if they can e.g. in ulcerative colitis repeated attacks of tropical 
diarrhea may lead to the disease becoming more severe, Uncontrolled hypertension 
can also be associated with problems in the tropics. 
In general the following conditions should be taken as relative contrain-
dication~ to travel in the tropics. 
1. Old age. 
2. Mental disease. (especially depression). 
3. Alcoholism. 
4. · Renal calculi. 
s; "Unstable" disease~ e.g. diabetes. 
6. · Hepatitis. 
7. S~vere skin disorders (particularly fungal). 
8. G-I disorders e.g. ulcerative colitis. 
g, Hypertension (unstable). 
10. Travellers with a history of significant tropical illness e.g. those who have . 
had severe amebic infections of the liver. 
PERSONAL INTERVIEW. 
The physician should aim to see all those intending to· visit the tropics, · 
for this initial interview represents an excellent opportunity for the physician 
to Practice some preventive medicine and to inform the traveller of simple measures· 
which may help him to avoid some disabling parasitic disease .and an example of this 
may be seen in the case of malaria.· For clinical experience soon reveals that many 
travellers, if not the majority, do not take their antimalarials correctly, usually 
stopping: too early, and if we can persuade them to take these chemoprophylactics 
as directed, then this alone is well worth while. This initial consultation can 
also be used to drive home the importance of commonsense precautions relating to 
food and water. All must be warned· that sufficient time must be set aside to allow 
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for acclimatization. Again the hazards of acute sunburn ,should be stressed. As has been 
mentioned some diseases constitut.e a contrai.ndication to travel in the tropics, 
but if the visitor to the tropics must make his journey, then certain.organizations 
can b.e of great use. Thus "!AMAT" (International Association For Med.ical Assistance. 
To Travellers-Empire State Bldg. 350 Fifth Ave., Suite 5620 New York, N:v. lOOOI) 
issues useful literature for the traveller to the tropics. Those on long term 
medication should carry adequate supplies of any medication which they may. need. 
J 
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PARADISE - THE THREE "P"S . 
.,..,5 Wiliii:W;i< 1'Wi:U. MUDUC W 
PROPAGANDA - (FOOD/DRINK/CLOTHING). 
PROPHYLACTIC - IMMUNIZATIONS. 
PROPHYLAXIS - AGAINST MALARIA. 
DO BE.CAREFUL WITH FOOD & DRINK. 
DO TAKE .ANTIMALARIALS. 
DO ACCLIMATIZE PROPERLY. 
DO WEAR SENSIBLE CLOTHING. 
DO NOT SWIM IN RIVERS/LA:K:ES. 
DO NOT WALK BAREFOOT. 
DO NOT OVEREXPOSE (SUN/HEAT). 
"YOU ARE WHAT YOU EAT" 
In general the main facets of the problem are covered by the following points. 
1. ACCLIMATIZATION. On arriving in the tropics, all should allow. sever.al days 
to adapt to the local conditions. This will allow recovery from the "time" 
barrier. Initial exposure to the sun should be short and increased gradually over 
the next few days. In high altitude areas several days should be allowed for 
acclimatization. Hot climates demand sensible clothing and ~otton materials 
are preferable to synthetic ones. Changes in diet also take their toll and most 
travellers have episodes of travellers diarrhea. 
2. FOOD. Milk and dairy products are best avoided and vegetable, meat or fish 
dishes must be well cooked, Salads are dubious, unless the 1t:isitor prepares them 
himself (care water). Where fruit is concerned, it is advisable .to stic;k to. items 
which can be peeled by the. traveller. If milk is to be taken it must be boiled 
before use. 
3. WATER & DRINK. Care must.be taken with water supplies, and where these are of 
poor quality, tablets such as Halazone can be used to render the water safe for 
drinking. Filtration methods are not usually satisfactory. In general all water 
should be boiled before use. Bottled beer is usually safe, but the label "bottled" 
water means little. Ice-cubes must not be made with unsafe water, and it must be 
remembered that if the local water is unsafe for drinking, then it is not suitable 
for dental use. Fluid! input should be generous·.in the tropics~ but extra salt is'. 
only needed if hard physical work is being undertaken. 
4. SWIMMING. in some tropical zones e.g. parts of Africa and the Middle-east, 
it is best not to swim in .fresh water as there is a risk of contracting 
schistosomiasis. 
5. BAREFOOT WALKING. In most tropical regions it is not a good idea to walk 
barefoot on the' ground as some parasitic infections e.g. hookworm can be acquired 
in the way. 
6. ANTIMALARIALS. (also see notes on malaria). The.initial interview represents 
a supreme opportunity for the physician to drive home. the importance of taking . 
antimalarials correctly, for after a spell in a hot climate many subjects take the 
medication incorrectly or not at all. 
7. DIARRHEA. After venturing into.the tropics most people experience diarrhea 
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. and although this is. often brushed off as being·inocuous, all travellers should 
!!eek medical aid if the diarrhea persists, or is accompanied by a high fever or by 
the passage of blood ( in particular it is important to rule out amebic infections). 
8. A MEDICAL ARMENTARIUM FOR ALL ??. Many subjects consult with their physician 
· because they wish to travel with medication for each a_nd every illness. All cases 
must be assessed on their own merits, and the following items represent a basic 
list, additional items being added as necessary. 
A. ANTIDIARRHEAL PREPARATION. Diphenoxylate-atropine preparations are useful in 
control.ling diarrhea, or alternatively kaolin mixtures can be taken. Some pre-
parations e.g. iodochlorhydroxyquin, are best avoided for they have little efficacy 
and may mask ·amebic infections, and· significant adverse reactions are sometimes 
associated with their use. 
B. ANTIFUNGAL PREPARATIONS. Fungal infections of the skin are by no m"eans rare in 
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the tropics and a good antifungal cream should be taken on the trip. (e.g. tolnaftate). 
C. ·ANTIHISTAMINES. Systemic anti.histamines are preferable to local preparations 
as far as allergic·reactions to insect bites etc. are concerned. 
D. ·WATER DECONTAMINANT ·PREPARATIONS.Where water supplies are unsafe water decont-
aminant tablets {e.g. Halazone) are useful. 
E. ANTIBIOTICS ??. The place of these compounds in the travellers medical kit is 
a vexed one, but where the individual can be trusted to use a modicum of commonsense, 
there is no valid reason why the subject cannot be informed as to the correct 
indications for these drugs, particularly when the itinary takes in isolated areas. 
F. OTHERS. Depending on the type of travel involved other items.may be indicated 
e.g. analgesics. 
IMMUNIZATIONS 
Although the health risks of travel in the tropics are appreciated by some, 
many visitors to these areas travel in woeful ignorance, for travel agencies and 
airlines paint the tropics in glowing romantic.colors and ~o little or nothing to 
warn the.fr patrons of the potential hazards. Often the traveller is led to believe 
that. if he has all the prophylactic immunizat}ons, then no parasitic infection 
Will trouble him. With reference to the various immunizations, ~he requirements 
for these vary from time to time and it is not possible to draw up comprehensive 
lists for each and every region. Subjects must realise that they have to allow 
plenty of time in which to receive the various proceedures. All visitors to the 
tropics should be immunized against smallpox, poliomyelitis, typhbid, tetanus and 
cholera, but some areas-warrant other preparations also (e.g. typhus). The 
doses given below are only examples and different preparations may need different 
doses. 
1 . SMALLPOX. 
Both primary vaccination and revaccination, are valid for 3·years, the primary 
proceedure being valid 8 days after vaccination and the rev·accination being valid 
at once. Contraindications to vaccination include; 
A. Eczema. 
B. Acute illness. 
C. The administration of another live virus vaccine during two weeks before or · 
after the vaccination. 
D. Gamma-globulin abnormalities and blood dyscrasias. 
E. Women -in the first trimester of pregnancy; 
F. Corticosteroid therapy or immunosuppressive therapy. 
2. YELLOW FEVER VACCINATION. 
This is valid 10 days after the primary vaccination and remains valid for 10 
years, the revaccination being valid at once. The vaccine should not be given 
to children below the age of 9 months. The vaccine is needed for such areas as 
tropical Africa, South and Central AmeriCa, If smallpox vaccination is first 
performed there should be an interval of at least 21 days before.yellow fever 
vaccine is administered. If yellow fever vaccination is carried out first, at 
least 14 days should elapse before smallpox vaccine is given. (This period can 
be shortened if necessary, but should be at least 4 days). 
3. CHOLERA. 
Whereas smallpox and yellow fever vaccines offer good protection against the 
respective diseases, cholera prophylaxis is not so eff1cient. The vaccination 
is valid for 6 mon~hs, beginning 6 days after the primary proceedure, and where .re-
vaccination is con.cerned it is valid from the date given and again lasts 6 months· 












The vaccine is given subcutaneously. 
ADULTS. 
First dose of 0.5 ml. followed by 1.0 ml.3-4 weeks later. A third dose of 1.0 ml. 
is desirable (3-4 weeks after the second dose). 
Children under 5 years of age; first dose 0.1 ml. 1hen second and booster doses 
are of 0.3 ml. 
Children 5-10 years; first dose of 0.3 ml. Then second and booster doses of 0.5 ml. 
Children -0ver 10 years should receive the adult dose. 
The disease can appear in ·most ·parts of the wor.ld, as the recent outbreaks 
have shown, and the vaccine is recommended for all visitors to the tropics. 
4. POLIOMYELITIS. 
This infection is prevalent in many tropical areas, and·all visitors to these 
zones should. have appropiate protection. 
5. PARATYPHOID-TYPHOID. 
Although this vaccine offers some protection against the above enteric infections, 
these diseases still pose a risk to the subject, particularly when there is exposure 
to constant infection. Different strength vaccines are available, but typical doses 
are; (given subcutaneously) 
ADULTS .. 
Initial course- First dose-0.25ml. 
Second dose - 0.5 ml; given 3-4 weeks after the first dose. 
Third dose - I.O ml; given 3-6 months after the second dose. 
When time is at a premium the intervals can be decreased to 10-14 days. 
Children under the age of 10 years are given half of the adult dose. 
Reinforcing doses of 0.5 ml. are given at least every 3 years. Where special risk 
factors are involved, booster doses can be given every 1-2 years. Smaller doses 
.of the vaccine can be given by the intradermal route. 
6. TETANUS. 
Vi sit.ors to the tropics should have adequate protection against tetanus. However 
it should be noted that although the administration-of any biological preparation 
carries.the potential risk of a severe allergic reaction, special care should be 
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taken with tetanus toxoid products as severe local and systemic reactions are not 
uncommon. in those who have had repeated tetanus toxoid injections. 
7. TYPHUS VACCINE. 
This is not generally recommended for all travellers to the tropics, but rather for 
those at special risk (e.g. in Vietnam or Laos). It is used to prevent typhus of 
the endemic type. 
ADULT DOSE - given subcutaneously. Initial course of 2 doses of r:o ml. at. 
intervals of 10 days, Reinforcing doses of I.O ml. annually are given at. the 
commencement of· the ty~hus season. 
Precautions; the vaccine should not be given to those with a history of·hypersensit-
ivity to egg protein. 
8. PLAGUE VACCINE. 
Most travellers to the tropics do not require this vaccine. Even when it is 
used only partial protection against the disease is offered and local and general 
reactions may be severe. 
9. GAMMA GLOBULIN. 
Infectious hepatitis is common in many tropical regions, and it would appear that 
human immune serum globulin can offer some protection against the disease for 
about 6 months. After that length of time it is likely that th~ individual has 
some active immunity. Repeated use of gamma globulin can sensitize the subject 
to the protein components of the injection. Gamma globulin should be given fairly 
near the departure date and at least some 12-14 days after the last of any other 
vaccination or immunization. 
Adults can be given 5.0 ml. I.M. 
IMMUNIZATION SCHEDULE. 
Several routines have been recommended, but the following will serve as a guide 
and are based on the guidelines of Cannon.· 
A. This is used where the subject has plenty of time available before his 
journey. Cholera vaccine can· be given at the end of the course. 
Week l. Yellow Fever vaccine. 
Week 4. Smallpox vaccination. 
Week 7. Tab(!). Tetanus (I) 
Week 10. Polio vaccine. 
Week 13. Tab (2). Tetanus (2) 
Week 16 •. Polio vaccine. 
8. 
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Week 22. Po+io vaccine. 
Week 39. Tab (3). Tetanus (3). 
B. This routine is for those who have less time available, 
Day 1. Yellow fever/Cholera (l)/Polio(l). 
Day S.· Smallpox/Tab/Tetanus (1). 
Day 11~. Cholera (2). 
Day 28. - Polio (2)/Tab/Tetanus (2). 
Any further doses are given later as required. 
REINFORCING DOSES. 
Smallpox vaccine - every 3 years. 
Yellow Fever vaccine - every 10 years. 
Cholera vaccine - every 6 months 
Polio vaccine - every 3-5 years. 
T.A.B. - every 3 years (every 1-2 years where spe.cial risks involved). 
Typhus vaccine - annually (at beginning to the typhus season). 
9. 
N. B. WHERE ANTIMALARIALS ARE INDIC.:'.TED THE PHYSICIAN SHOULD STRESS THE IMPORTANCE 
OF TAKING THESE CORRECTLY AND OF CONTINUING TO TAKE THEM AS DIRECTED AFTER LEAVING 
THE TROPICS (please see notes on malaria). 
Although Ethiopia appears to be the only.country where there is a continuing tran-
mission of smallpox, some countries still require vaccination for entry. All 
travellers should verify the situation for each country to be visited. 
_,._, ·' 
"SOUVENIRS FROM THE TROPICS" 
/ED:MA - FILARIASIS/TRYPANOSOMIASIS/TRICHINOSIS. 
. /NODULES-ONCHOCERCIASIS/LEPROSY/LEISHMANIASIS. 
JI "SPOTS"-TYPHOID/TYPHUS/SMALLPOX. 
~ \ ULCERS-LEISHMANIASIS/LEPROSY. . . . 
~{'- jj~ Yi EYES:-TOXOCARA/FILARIASIS/TRACHOMA/LEPROSY. 
~-~ (__. :\ R.S.-"ASTHMA" (=WORMS)/TUBERCULOSIS. . 
\: ~- \ LEISHMANIASIS. 






SPLENOMEGALY-ALW"AYS RULE OUT MALARIA. 
~.-TRYPANOSOMIASIS/LEPROSY. 
·c.v.s.- s. AMERICAN TRYPANOSOMIASIS. 
V.D. 
CHAPTER 2. 
THE RETURN OF THE TRAVELLER. 
A. TAKING THE HISTORY. 
UNDE VENIS ??. ("WHERE HAVE YOU BEEN?") 
DID YOU HAVE A FEVER?. 
DID YOU TAKE ANTIMALARIALS?. 
DID YOU HAVE SEVERE DIARRHEA?. 
DID YOU WALK BAREFOOT OUTDOORS?. 
DID YOU SWIM IN FRESH WATER?. 
ETC. 
Most subjects who-return from the tropics feel well on their homecoming, 
but it is still advisable that they consult with a physician on their return. 
Some parasitic diseases may remain dormant for many years and are only detected 
when routine screening tests are instituted. Thus it is essential to take a 
good history, perform a physical examination and carry out basic screening tests· 
on all :those who have been to the tropics, whether they have symptoms or not. 
Certain points in the case-taking are worthy of emphasis. 
A full geographical history is a necessary pre-requisite for the diag·nosis 
of any tropical disease and Maegraith's master words "Unde Venis" (where have you 
been?,) 'must now be directed at all who return from the tropics, and the countries 
visited and the duration of each visit should be noted, for often the itinary will 
suggest the probable diagnosis. Thus for example a prolonged stay in West Africa 
would bring the possibility of such infections, amongst others as malaria, amebic 
dysentery or filariasis to mind. Many who have had a fever are usually vague about 
the exact details but as far as endemic'zones for malaria are concerned,·any 
traveller who returns from such an area with history of unexplained fever SHOULD 
BE ASSUMED TO HAVE MALARIA UNTIL PROVED OTHERWISE. All subjects should be quest-
ioned as to whether antimalarials were taken. and if so were they taken as directed. 
The fact that the subject states that these drugs were taken does not rule out the 
possibility of the malaria parasite being present (see notes on malaria). 
Visitors are often unaware of the fact that only one bite from the relevant 
infected mosquito is needed to contract the disease, and even a-short stay at 
an airport in.a malarious zone might raise the possibility of this disease being 
Present. Thus exact details of the itinary must be obtained,and in particular the 
physician has .to be aware of all stopover visits. Again the examiner· should keep in 
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mind the fact that although many global regions are now said to be free from 
malaria, the disease does not follow any clear cut geographical boundaries. 
Diarrhea remains a common complaint for many who return from the tropics. 
Amebic infections, asymptomatic or oth~rwise, are by no means rare and because 
this infection can be associated with much disability if untreated, the physician 
should. always keep the disease in mind whenever there is a history of diarrhea. 
Details of any self-medication are useful since tetracyclines and iodochlohy-
droxyquin may mask the presence of an·amebic infection. 
In locations where the hookworm thrives a history of walking barefoot outdoors 
would incline one to suspect the presence of this parasite. Urinary tract symptoms 
should alert the examiner to the possibility of schistosomiasis, especially when 
the visitor admits to a history of swirraning in fresh water in such areas as 
tropical Africa. A history of hematuria obviously demands a full investigation, 
but it is worth noting that renal calculi are not uncommon in the person who 
makes his stay in the tropics a lengthy one. A history of respiratory symptoms 
may be associated with some helminthic infections, and thus ascaris can produce 
an asthma-like episode, particularly in the early_stages of the infection. 
Medical histories for all the members of the family must to obtained and 
no temporal limits should be placed on.the history as some parasitic conditions 
can make their presence felt many years after the initial exposure (~.g. amebic 
infections). 
THE RETURN OF THE-TRAVELLER - THE PHYSICAL EXAMINATION. 
A full physical examination should be carried out on all who return from 
the tropics. Sometimes the elicitation of a specific physical sign will suggest 
a possible diagnosis. It is not proposed to cover all the possibilities here, and 
only a few examples are mentioned. Localized edema may_be observed in filariasis. 
trypanosomiasis, trichinosis and some intestinal helminthic infections. In South 
American trypanosomiasis the characteristic unilateral facial edema which is 
sometimes seen is known as Romana's. sign. Calabar swellings are painful-edematous 
areas, often near joints, and are seen in infections caused by the filarial wonn, 
Loa loa (seen in tropical Africa). The well defined zones of edema observed in 
association with parasitic disease are often fleeting in nature. Skin nodules are 
associated with onchocerciasis, leprosy and leishmaniasis. The manifestations 
of leprosy are protean and include macules, ulcers and anesthetic hypopigmented 
areas of skin, in addition to the wide range of other clinical presentations. 
Fungal lesions of the skin are not uncommon in this groµp of travellers. 
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"Creeping'' cutaneous eruptions can indicate the presence of such parasites 
as strongyloides or hookworm. Skin ulcers are not commonly observed in this 
group of subjects, and such entities as tropical ulcer are commoner in the 
indigene rather than in the visitor to the tropics. Cutaneous leishmaniasis 
may scar the skin. Erythematous and other rashes may be associated with a wide 
range of parasitic infections including filariasis and schistosomiasis. 
Tuberculosis is prevalent in many tropical areas and must always be kept in 
mind when discussing the differential diagnosis of respiratory illness in this 
group of subjects. Respiratory signs suggestive of asthma raise the possibility 
of such parasites as ascaris, visceral larva migrans or schistosomiasis being 
present, particularly where there is an associated eosinophilia. Bouts of coughing 
are sometimes seen in the Katayama syndrome (fever/urticaria/eosinophilia) due to 
SChistosomiais. Paragonimiasis may also produce severe coughing and hemoptysis. 
Amebic pulmonary abscess may cause significant pulmonary changes. Although 
localized lymph node enlargement is a fairly non,-specific finding it may herald 
tuberculosis, filariasis, trypanosomi-asis or leishmaniasis. Enlargement of the 
"liver or spleen brings a host of potential causes to mind, and all the usual r 
''Commoner" causes must be eliminated. Clinical jaundice would bring to mind 
Such tropical entities as·falciparum malaria, hepatitis, liver flukes (clonorchis) 
and visceral· leishmaniasis. Hepatomegaly can be observed. in many tropical conditions 
including; 
1. Malaria. 
2. Amebic infections. 
3. Visceral larva migrams. 
4. Hepatitis. 
5. Visceral leishmaniasis. 
6. Schistosomiasis. 
7. Liver fluke infections. 
Again the causes of splenomegaly are legion, but malaria must always be on 
the top of the list of suspected culprits. Parasites can invade most of the body 
tissues. Thus the eye may be involved in leprosy, trachoma, onchocerciasis and 
lciiasis. Various worms and their eggs may involve the C.N.S. and if coma is 
present then trypanosomiasis, cerebral malaria or hepatic coma in laterschistos-
Omiasis should be considered as far as "exotic" diseases are concerned. 
RETURN OF THE TRAVELLER - LABORATORY INVESTIGATIONS. 
As has been mentioned it is highly desirable that ill visitors to the tropics 
have basic screening tests for parasitic disease on their return. The temple 
of truth for most tropical diseases .remains the laboratory, and the high priest 
is to be found in the person of the experienced laboratory technician, for 
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however careful we are in our history taking and physical examination, we are 
dependent on efficient efficient laboratory techniques for the detection of most 
parasites. The history and physical findings dictate the extent of any invest-
igations, but in general the following basic tests should be considered; 
1. Examination of fresh stool samples. (minimum of three). 
2. Examinat.ion of the blood. 
3. Urinalysis. 
4. Biochemical tests as indicated. 
5. Chest x-ray. 
6. Other tests (e.g. skin testing & tests for V.D. etc). 
A thorough examination of the stools ranks high on the list of priorities 
and a minimum of three fresh stool samples must be obtained. Ideally the samples 
should be produced.at the laboratory itself. but if this is not feasible then 
the samples must reach the laboratory within one hour after being passed. Pre-
served stool specimens which are mailed to the laboratory are very much a second 
best and should not be relied upon to exclude such infections as amebic dysentery. 
Often patients do not take kindly. to the prospect of producing several stool 
samples, but they must be informed that a single negative report does· not rule out 
parasitic disease. Parasites identified by examination of the stools include; 
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Sometimes the 'identified organisms are non-pathogenic e.g. Entameba coli, 
iodoameba butschlii and endolimax nana. In· cases of persistent diarrhea bacterial 
culture and sensitivity studies are also indicated, particularly to rule out 
salmonella and shigella infections. 
Blood studies vie with examinations of the stools in importance as far as 
diagnosis is concerned, and in some instances a solitary abnormal finding. such 
as a persistent eosinophilia, may be the only finding to show the presence of 
a parasite. The field of. tropical anemias is a subject in itself, but when reviewing 
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the etiology of anemia in a subject who has returned from the tropi'cs, the physician 
would do well to keep malaria, hookworm and schistosmiasis in mind. Also where 
applicable the various hemoglobinopathies would need to be considered as well. 
Occasionally antimalarials can produce anemia e.g~ pyrimethamine and primaquine. 
Although the raison d'etre of doing a blood film in those returning from the tropics 
is the detection of malaria, such a technique is useful in screening for 
trypanosomiasis and the microfilariae of filariasis. Day films should be done and 
where the traveller has taken in such an area as the Pacific Islands, late night 
films (the blood being taken between the hours of 10 p.m. and 2 a.m.) are required 
to identify microfilariae. Sometimes blood culture methods are useful e.g. for 
the diagnosis of typhoid or brucellosis. 
Serological tests have a place also e.g. latex reactions fa~ extra-intestinal 
amebic infections, complement fixation tests for trichinella spiralis or schist-
osomiasis. A leucocytosis is too non-specific to be of much use but the presence 
of a leucopenia is a little more helpful and may be associated with kala-azar, 
typhoid or brucellosis. An eosinophilia is always a significant finding and 
parasites producing such a change include filariasis, schistosomiasis, ascariasis, 
hookworm, larva migrans, trichinosis and tropical eosinophilia. Biochemical invest-
igations remain non-specific but li\fer function abnormalities often reflect the 
relatively common viral hepatitis of the tropics. 
Examination of the urine is used to detect the eggs of schistosoma hematobium. 
Examination of the sputum may occasionally reveal the trophozoites of E.histolytica, 
the eggs of paragonimus or the larvae of ascaris. The possibility of TB. must 
always be kept in mind. 
Intradermal tests can be utilized to demonstrate some infections e.g. 
schistosomiasis. A chest x-ray and suitable blood test for V.D. should always be 
part of the routine check-up. 
X-ray examination can be useful in the diagnosis of imported diseases. Thus 
screening of movement of the diaphragm may assist in the detection of an amebic 
hepatic abscess, though a liver scan would be needed to confirm the diagnosis. 
Intestinal amebic infections can produce evidence of intestinal ulceration. 
a conical cecum, and spasm of the ascending colon. Sometimes amebomas are 
mistaken for neoplasms. Giardiasis can be associated with irregularities of 
the second portion of the duodenum. Rim calcification in the bladder wall and lower 
ureters is a sign in schistosomiasis (S. hematobium). Schistosomiasis (S. mansoni) 
sometimes causes changes similar to Crohn's disease. 
Altha.ugh rare in the visitor, Chaga's disease (South American trypanosomiasis) 
may be associated with ventricular aneurysms, paralysis of the esophagus and a 
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dilated colQn and x-rays are useful in confirming the diagnosis. X-ray of the 
chest, in subjects with ·tropical eosinophilia, may reveal a diffuse mottling. 
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CHAPTER 3 . 
MALARIA. 
This disease is worthy of .consideration by.most physicians, not only because 
it is a fascinating entity, but because it is also of great significance as 
far as world travel is concerned. It is a vast subject in itself, and only a 
few aspects of the problem as they relate to the field of general medicine 
are reviewed here. Although themajoritiof people exposed to this infection 
(estimated at over 350 million subjects) are obviously indigenes of tropical 
zones, .it is clear ,that more and more citizens from temperate climates are 
penetrating malarious regions. The usual form of transmission of the para.site 
is by the female anopheline mosguito, and the parasite, a protozoan of the genus· 
Plasmodium, is present in many tropical .areas. Infection may be· associated with 
one or more species of the parasite, but the main. clinical forms of the disease 
can be classified; 
A. Malignant malaria (caused by P.falciparum). 
B. The vivax group (caused by P.vivax, P.ovale or P.malariae). 
- . 
It is worth noting that the parasite can be transmitted by blood transfusions 
or by use of contaminated syringes. 
As P.falciparum represents the mafn hazard to human health, this is the parasite· 
which is mainly considered here, but it should be remembered ·that mixed infections 
may occur. As untreated malaria may have a fatal outcome, it should be a golden 
rule for all physicians to assume; 
THAT IF A SUBJECT GIVES A HISTORY OF PYREXIA AFTER RETURNING FROM A MALARIOUS 
AREA, THEN MALARIA SHOULD BE DEEMED TO BE PRESENT UNTIL PROVED OTHERWISE. 
The following aspects of the disease are now considered, 
1. CHEMOPROPHYLAXIS. 
2 .. CLINICAL FEATURES AND DIAGNOSIS. 
3. TREATMENT OF MALARIA. 
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l.CHEMOPROPHYLAXIS 
Cl inca l experience soon sho~1s that many visitors to the tropics take 
antimalarials incorrectly and the physician is in a good position to advise on 
this point when the traveller first presents himself for the various immu;1izations 
-
required for visits to the tropics, for travel agents and airlines do little 
to warn of the risk of malaria. The following notes mainly relate to the 
non-immune subject i.e. one who usually resides· outside an endemic malaria zone, 
but it is worth noting that when the indigene from a malarious area spends a 
significant time in the Western world he may forfeit part of his protection 
against the malaria parasite and when he eventually returns home he may well 
- . 
need to be regarded as a non-immune who merits chemoprophylaxis. 
Which travellers should be provided with these drugs? In some instances 
there is little doubt that protection against the disease is indicated e.g. 
where the itinerary takes in West Africa, but some zones are not so obviously 
associated with the parasite and the WHO publication "Information on malaria 
risk for international travellers"(reprinted from the WHO Weekly Epidemiofogical 
Record No. 3, 1973 pp. 25-45) provides useful information on this point. 
The visitor to the tropics must be carefully questioned as to the exact details 
of his proposed journey and .should be warned that only one bite from the relevant 
mosquito is needed to contract the disease, and thus even a short stay at an 
airport in a malarious region would warrant the use of a antimalarial. The 
parasite still reigns supreme in such areas as tropical Africa, most of South-
East Asia, much of South America, some of Centrai America, parts of the Middle 
East and certain South Pacific regions. 
When considering the choice of preparation one obvious prime factor to take 
into account is the possibility that the parasite may be resistant to a particular 
drug. Thus ~.falciparum is resistant to chloroquine in parts of South-East Asia 
and South America, but so far this problem does not extend to Africa. Where there 
is some doubt as to whether a drug resistant parasite is contained in a certain 
region, a·good case can be made out for using a combination of drugs. In some 
highly malarious zones e.g. parts of West Africa, efficient chemoprophylaxis may 
only be achieved.when the drugs used·~re taken in doses.~hich are larger than those 
usually recommended. The absent-minded individual may be better suited with a 
"once-a-day" rather than a "once-a-week" preparation. Chemoprophylaxis should 
.be commenced prior to entering the malarious area and must be taken regularly 
throughout the stay. On leaving the endemic region the drugs are required for 
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at least a further four weeks. and preferably should be continued for a period 
of six to eight weeks. The administration of an antimalarial is no guarantee 
that the traveller is fully protected against the disease. and significant 
attacks of malaria may occur even when chemoprophylaxis is instituted 
because: 
1. The parasite may have been resistant to the drug used (particularly with 
P.falciparum infections). 
2. The drug may have been taken incorrectly, or severe diarrhea could. lead 
to impaired absorption of the medication. 
3. "Breakthrough" infection can occur. 
4. In some forms of malaria (involving P.vivax. P.malariae or P.ovale). 
cessation of a suppressant drug may be followed by a relapse at a later date. 
(see notes on primaquine). 
All subjects should be warned about the potential adverse reactions of 
these drugs, but it would appear that in the usual antimalarial doses serious 
adverse effects are rare. However, the increasing use of combinations of.agents 
and the administration of larger than the usual doses in some zones might change 
our ideas in this respect. As has been mentioned the ideal antimalarial is still 
only a concept, and the physician must convince ,the traveller that such entities 
as unexplained fever or malaise in a person who has visited an endemic area should 
be assumed.to be due to malaria until proved otherwise. Even in present times 
cases of malaria are still being missed. Although fever rem~ins the cofllllonest 
present feature, the illness can present with the signs and symptoms of any acute 
infection. and in some instances the complications dominate e.g. acute hemolytic 
anemia. cerebral malaria. hyperpyrexia, algid malaria, renal failure, hepat1c 
dysfunction or dysenteric states. In all cases a rapid qiagnosis is mandatory 
and treatment must be instituted with. alacrity. 
With reference to malaria, the term chemciprophylaxis is really a misnomer, 
for at present we have no safe and efficient preparation capable of destroying 
the sporozoites i.e. the infective forms of the parasite. and in practice the· 
drugs we employ are mainly used for their suppressant effect. Before discussing 
some of the more commonly used antimalarials it is useful to review a few of the 
terms involved. 
Causal prophylactic drugs. 
(Primary tissue schizontocides) 






















of the erythrocytes is prevented. Pyrimethamine and chloroguanide are good-causal 
prophylactics against P.falciparum. Primaquine is also effective in this respect, 
but it is too toxic for routine use. 
Suppressive drugs. 
(Blood schizontocides) 
These inhibit the asexual erythrocytic stages of the parasite i.e. the 
subject has no significant clinical symptoms. The exoerythrocytic stages of the 
parasite remain intact, and at a later date the subject may have attack!:. of 
malaria long after the drug has been discontinued (this does not apply to P.falci-
parum infections where efficient suppression eliminates the infection). In 
order to eradicate the exo-erythrocytic stages a drug such as primaquine must 
also be administered. 
Radical curativecdrugs.(Secondary tissue schizontocides)_ 
These compounds act on the secondary exo-erythrocytic stages of the parasite. 
Primaquine, an 8-aminoquinoline drug is used for this purpose, and is given 
to prevent relapses in infections due to P. vivax, P. malariae or P. ovale. 
Gametocytocidal drugs. 
These act on the sexual forms of the parasite, some destroying the gametocytes 
in human blood, whilst others prevent the development of the gametocytes in the 
mosquito. They have little clinical application. 
It is· worth noting that there is a basic difference between P.falciparum 
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and the other parasites associated with human malaria, viz. in P.falciparum infections 
there. is no obvious re-invasion of the liver cells, and because there is no sec-
ondary tissue stage, efficient suppression of the parasite results in a complete 
cure. 
Some common antimalarials 
1. Chloroquine.-
This 4-aminoquinoline compound was first synthesized in 1934 and has been 
used in both the chemoprophylaxis and therapy of malaria. Because ·of its efficacy 
in the acute attack, and taking into account the problem of the drug resistant 
parasite, some are of the opinion that the drug should be reserved for treating 
the acute malarial episode. In view of its potential for serious toxic effects 
on the eye, chloroquine_must always be administered with care. The drug has an 
_effect on the asexual erythrocytic forms of the parasite. However it should be 
noted that it does not prevent relapses in subjects with P. vivax~ P. malariae or 
P. ovale infections. When given as a suppressive for P.falciparum the drug results 
in a complete cure being obtained (providing the parasite is not resistant). It 
should not be given to those with retinal disease-or visual field defects and is 
contraindicated in those with a history of a hypersensitivity to the 4-aminoquin-
ol ines. In an effort to prevent, and overcome, the problem of the resistant 
parasite the compound has been given in combination with other antimalarials e.g. 
pyrimethamine, primaquine and dapsone. 
Dose (for suppressive effect) 
Adults (Chloroquine phosphate) 
An oral dose of 300 mg of the base is given once a week (on the same day each 
week). The medication is commenced two weeks before entering the malarious zone 
and must be taken for at least four weeks after leaving the endemic area fpreferably 
taken for six to eight weeks): In high risk areas 300 mg of the base should be 
taken twice a week. 
Although it i~ well tolerated in the usual antimalarial doses, the compound 
is not without potential adverse effects. It may produce severe reactions in those 
with psoriasis or porphyria and should be given with care to .those with hepatic 
dysfunction. In general the most serious adverse reactions have been reported 
in association with the long term administration of the preparation. Eye changes 
remain the most significant threat and include retinopathies, corneal deposits, 
macular 1esions and optic atrophy. Now that antimalarials are sometimes employed 
in relatively high do~es, it would seem prudent to advise all subjects who are 
likely to be on chloroquine for any length of time to have regular ophthalmic ex-
aminations, particularly as retinal changes may ~e asymptomatic. Eye changes can 
also occur after the drug has been discontinued. Other reported adverse reactions 
include headache, pruritus, gastro-intestinal upsets, psychotic episodes, con.vul-
sions, neuromyopathies, blood dyscrasias and skin changes. Amodiaquine is a 
4-aminoquinoline compound and has similar properties to those of chloroquine. 
2. · Chloroguanide (Pal~drine) 
This acts as a causal prophylactic for P.falciparum and has a suppressive 
effect on the other parasite~ associated with human malaria. When given in the 
usual antimalarial doses it is relatively non-toxic. Some strains of the parasite 
are resistant to the drug, and there·may be .cross resistance with pyrimethamine. 
It is very suitable for use in children. 
Dose - Adults 
The oral dose is 100 mg daily. In high risk areas 200 mg of the drug should 
be taken daily. 









for at least four weeks after leaving the endemic area (preferably taken for six 
to eight weeks). 
3. Pyrimethamine 
Pyrimethamine acts as a causal prophylactic for P.falciparum infections and 
has a suppressive effect on the other parasites causing human malaria. The pre-
paration is well absorbed and need only be taken once a week. In the usual doses 
it has few adverse effects, but larger doses can produce a macrocytic anemia. 
Resistance to the drug occurs and there may be cross resistance with chloroguanide. 
The drug prevents maturation of the gametocytes in.the mosquito. Pyrimethamine 
has been given in association with other antimalarials e.g.·dapsone and chloroquine~ 
Dose - Adults 
The usual antimalarial dose is 25·mg to 50 mg given orally once a week. 
The drug is commenced just prior to entering the.malarious zone and continued 
for at least four weeks after departing from such an area (preferably taken for 
six to eight weeks). 
4. Quinine and mepacrine 
Although quinine has been used as a antimalarial, its present role is. mainly 
in the therapy of acute malaria, particularly in P.falciparum infections which 
are resistant to chloroquine. Mepacrine has also been used as a suppressant for 
malaria, but it is now mainly indicated .for the therapy of such diseases as giar-
diasis and tapeworm infections. 
5. Primaquine 
Although this toxic 8-aminoquinoline drug is essentially used for the radical 
cure of P.vivax, P.malariae and P.ovale malaria, it has been given in association 
with other drugs for the chemoprophylaxis of malaria (e.g. with chloroquine and 
.dapsone). It has a causal prophylactic effect, but in view of its potential toxicity 
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it is not used for routine chemoprophylaxis .. Drugs such .as chloroquine or chloroguanide 
will not preveni relapses in P. vivax, P.malariae or P.ovale ~alaria, and as these 
relapses are due to the secondary exo-erythrocytic·stages of the parasite in the 
liver, in order to prevent relapses and provide a radical cure of the disease, 
a c·ourse .of primaqui ne is given. These secondary exo-erythrocyti c phases do not 
apparently take place in P. falciparum infections. Adverse effec.ts associated with 
the drug incJ_ude abdominal pain, methemoglobinemia, hemolytic anemia (in subjects 
'·"'"-· .. 
with a glucose - 6 - phosphate dehydrogenase deficiency a severe hemolytic crisis 
may be induced) and granulocytopenia. The drug should not t.e, administered to 
those who have been recently on mepacrine as severe toxic reactions may be produced. 
In adults an oral dose of primaquine 15 mg of the base is given daily.for 14 days. 
6. Other drugs. 
Dapsone and other sulfones have been used as antimalarials for some time, 
but they are not satisfactory when given alone and are usually given in association 
with other drugs. Thus dapsone has been given in combination with pyrimethamine· 
on a weekly basis, and has also been used with chloroquine and primaquine. With 
reference to P.falciparum, dapsone has a schizontocidal effect, but is less. 
effective against P.vivax. It does not act on the tissue stages of the parasite. 
As the sulfones can produce severe adverse reactions including hemolytic anemia 
(especially in those with a glucose - 6 - phosphate dehydrogenase deficiency), 
agranulocytosis or methemoglobinemia, they are not recommended for routine use. 
The antimalarial activity of the sulfonamides has.been known for many years, 
but although they have been given in association with other chemoprophylactic drougs, 
their main indication is the therapy of the acute attack, particularly where the 
drug resistant parasite is involved. The combination of sulfadoxine and pyrime-
thamine has been used for suppression of the parasite, but the place of such 
combinations in the chemoprophylaxis of the disease is not yet fully established. 
Also the long term use of sulfonamides-carries a significant risk of adverse·.re-
actions, and in addition to the emergence of drug resistant parasites, bacteria 
may become resistant as well. 
Cycloguanil has a long lasting effect against some strains of the parasite 
and is given as a single·intramuscular dose. It is effective for several months, 
but there have been reports of parasite resistance. 
Antimalarials and pregnancy. 
With reference to the use of antimalarials in pregnancy, the physician must 
assess the benefit to risk ratio for each individual subject, but it .is generally 
accepted that the potential .risk of malaria justifies the use of these drugs in the 
pregnant subject. Combinations of drugs are probably best avoided, but on the 
whole the usual doses of antimalarials appear to be relatively safe when given 
during pregnancy .. 
The drug resistant parasite. 
The drug resistant parasite remains a significant problem as far as the 
chemoprophylaxis of malaria is concerned and even now we are unaware of all the 
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was first described in 1960 and essentially relates to P~falciparum. It poses 
a problem in such zones as South America and South~East Asi~. but at present it 
is not a significant entity in Africa. However mass chemoprophylaxis may well 
lead to a spread of the phenomenon.· Some strains of the parasite which are re-
sistant to chloroquine may also have a cross resistance to other antimalarials. 
In parts of Africa (e.g. Tanzania) P.falciparum has been found to be resistant 
to chloroguanide and pyrimethamine, and similar findings have been described 
in South-East Asia an.d South America. With reference to these two latter drugs 
resistance involving P.vivax, P.rnalariae.and P.ovale has also been noted. 
In an effort to prevent th.e emergence of resistant. strains 6f the parasite, 
and provide efficient chemotherapy when-the subject encounters the drug resistant 
parasite, combinations of drugs have b~en employed, particularly in such areas 
as Vietnam where drug resistant P. falciparum has been a problem. Many pennutations 
have been tried, including the following combinations: 
Chloroquine 300 mg. of base. plus primaquine 45 mg. of base - once weekly. (This 
routine has also been.combined.with daily doses of dapsone 25 mg.). 
or 
Pyrimethamine 12.5 plus dapsone 100 mg. -·once weekly. 
or 
Pyrimethamine 15 mg. plus chloroquine 150.mg. of base - 1-2 tablets weekly. 
or 
Pyrimethamine 12.5 mg. plus sulfadoxine (125~250 mg.) - once a week. 
Some of ·the sulfonamides (e.g. sulfalene) are of interest from the 
point of view of antimalarials, but at present their role in chemoprophylaxis 
is not fully established, and they have·mainly been used in the treatment of the 
acute attack. In view of the.potential toxicity of the sulfonamides~ there is 
some concern about their routine long term use. 
It should be noted that in areas where P.falciparumis resistant to 
chloroquine, chloroguanide may still be effective and combinations of drugs may 
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2. MALARIA-CLINICAL FEATURES AND DIAGNOSIS. 
A. CLINICAL FEATURES. 
"INCUBATION PERIOD". 
P.falciparum - about 12 days. 
P.vivax - 13-15 days (may be much longer) 
P.malariae - upto l month. 
FEVER. 
P.falciparum - primary attack is potentially the most threatening. In visitors 
to malarious areas, usually a quotidian fever is seen. Later a tertian fever 
may present, accompainied by a cold stage - lasting upto 2 hours, followed by a 
hot period (3-4 hours) and then a stage of sweating (2-4 hours). P.vivax can 
produce high fevers and there-may be severe malaise. Episodes of pyrexia_ on 
every fourth day occur in P.malariae infections (quartan malaria). The 
classical stages of the disease are not always seen. 
COMMONEST PRESENTING SIGN IS FEVER. 
In severe P.falciparum infections accompanied by shock, the temperature may 
be subnorma 1. 
Sometimes the subject may notice headache, backache or limb pains before the 
fever is obvious. 
OTHER CLINICAL FEATURES. 
The_ spleen is usually palpable by the second week and there may be some 
hepatomegaly. Jaundice ma~y be observed in cases with significant liver 
involvement. Nausea and vomiting are present in some instances. 
COMPLICATIONS OF FALCIPARUM MALARIA. 
These can develop at any stage.in the infection. 
(A) ALGID MALARIA. 
There is acute shock and death can occur with little warning. Adrenal 
failure may play a part in the synd~ome. 
(B) CEREBRAL MALARIA. 
24. 
Cerebral involvement can produce coma.· Also there may be hyperpyrexia. Convulsions 
are sometimes the presenting sign. 
(C) RENAL FAILURE AND BLACKWATER FEVER. 
Renal insufficiency can take place at any stage. In blackwater fever 
hemoglobinuria is seen, and this may be accompanied by vomiting and abdominal 
pain. The syndrome is not corrmon now but was essentially observed in non-immune 
l 
1 
subjects who had taken qu1n1ne. Treatment of the condition involves the routine 
chemotherapy for the malaria parasite and treatment of the renal failure. 
Corticosteroids and dialysis have also been employed. 
(D) SPLENIC RUPTURE. 
Spontaneous rupture of the spleen may occur in acute primary episodes of 
the disease. 
(E) HEPATIC FAILURE. 
With this complication the patient may complain of abdominal pain, nausea 
and v6miting and the prognosfs is usually poor. 
MALARIA-LABORATORY.FINDINGS. 
The blood findings show evidence of a hemolytic anemia. The sedimentation 
rate is .usually increased. There may be a leucocytosis with a increase in the 
monocytes, but sometimes a leucopenia is seen. Plasma albumin is decreased but 
there is usually an increase in· globulin levels: There may be evidence of impaired 
hepatic and renal function. The urine findings are usually normal but in cases 
of blackwater fever there may be hemoglobinuria. In episodes of pyrexia 
there is sometimes an increase in plasma potassium and blood sugar levels. 
DIAGNOSIS IS DEPENDENT UPON FINDING THE PARASITE IN BLOOD FILMS. 
MALARIA DIAGNOSIS. 
This a.spect of the illness can be considered as having three components. 
1. HISTORY "LINDE VENIS?" (Where have you been). 
2. BLOOD FILMS.· (Thick and Thin) 
3. PHYSICAL EXAMINATION AND OTHER INVESTIGATIONS. 
The history·is supremely important, and the master words of Maegraith, 
"Unde Venis" must be directed at all who return from the tropics. Many parts 
of the globe remain malarious, including much of tropical Africa, parts of 
North Africa, South America and some of Central America, much of Asia, parts 
of the Middle-east and some South-Pacific regions. If the traveller has visited 
such an area it should be determined whether antimalarials were taken as directed. 
It is worth stressing that; 
Only one bite from an infected mosquito is needed to acquire the parasite. The 
ideal antimalarial does not yet exist. 
Even if the subject took antimalarials the disease may still be present {please 
see notes on chemoprophyl axis). · 
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IF ANY SUBJECT WITH A PYREXIA, OR HISTORY OF PYREXIA, HAS RETURNED FROM A 
MALARIOUS AREA, THEN THE PHYSICIAN SHOULD ASSUME MALARIA TO BE PRESENT UNTIL 
PROVED OTHERWISE. 
With reference to the diagnosis of the parasite, the only certain way of 
confirming the disease is to detect the erythrocytic forms of the parasite in 
a suitable blood film and repeat films may be necessary. (Both .thick and thin 
films being done). Rarely sternal marrow· samples are !'leeded. Parasites are most 
numerous in the peripheral blood during or soon after the paroxysm. In primary 
falcfparum infections the fever may be very irregular and at times the parasites 
may be very scanty.in the blood. 
Although the infection can appear under several guises, fever is usually the 
main clinical pointer and the combination of fever, splenomegaly and·a.history 
of a sojourn in a malarious area should always raise the possibility if this 
disease. Besides the .blood film other diagnostic tests include complement 
_fixation, hemagglutination tests, and fluorescent antibody te-sts. 
TREATMENT OF.ACUTE MALARIA. 
The acute attack usually responds to chloroquine. 
ADULTS. 
Initial dose is 1.0 gm. (600 mg. of the base) of chloroquine phosphate, 
followed by an additional 500 mg. (300 mg. of base) some 6-8 hours later. Then 
a single dose of 500 mg. (300 mg. of the base) is given on each of two consecutive 
days. All doses given orally. 
INFANTS AND CHILDREN. (oral chloroquine phosphate). 
First dose of 10 mg; base/kg. (not exceed_ing .a single dose of 600 mg, of base) 
Second·dose of 5 mg. base/kg. (not exceeding a single dose of 300 mg. of.base) 
-six hours after the first dose. 
Third dose of 5 mg. base/kg 18 hours after the second dose. 
Fourth dose 5 mg. base/kg 24 hours after the third dose. 
All doses expressed/kg. of body weight. Supportive therapy is also needed including; 
1. Bed rest. 
2. Fluid balance & correction of electrolyte imbalance. 
3. Treatment of complications - renal failure and hyperpyrexia etc. 
The above regimen refers to the acute uncomplicated attack an~ sh~~ld result 




N.B. FOR A RADICAL CURE OF VIVAX, OVALE OR MALARIAE MALARIA CONCOMITANT THERAPY 
WITH AN 8 - AMINOQUINOLINE DRUG IS NEEDED. 
Thus adults should be given Primaquine orally for 14 days (15 mg./day), but 
this is a toxic drug and must be given with care, and may produce a severe 
hemolytic anemia (especially in subjects with a glucose-6-phosphate dehydrogenase 
deficiency) and methemoglobinemia. 
In children the dose of Primaquine is; 
4-8 years of age-total oral dose of 5.0 mg.-7.5 mg. once a day for 14 days. 
8-15 years of age-total oral dose of 10.0 mg.-15.0 mg. once a day for 14 days. 
Above doses refer to the base. 
The patient who is severely.ill may have some of the complications already· 
mentioned, -and in addition to chemotherapy each complication will need its own 
specific therapy. Where the subject is unable to tolerate oral medication, chlo-· 
roquine can be given intramuscularly but must be given with great care. Thus 
adults are given chloroquine hydrochloride 250 mg. (200 mg. of the base) I.M. 
every 6 hours (maximum dose being 1.0 gm~ daily-as soon as possib'Le a change 
should be made to oral.therapy). In emergency use quinine dihydrochloride'can 
.be given intravenously, adults receiving 600 mg. in normal saline (300 ml.) 
given slowly over half an hour. The dose can be repeated in 8 hours (maximum 
dose being 1800 mg. in 24 hours). Oral therapy should be substituted as soon as 
possible. Intravenous quinine may be associated with severe adverse reactions 
(especially on the C.V.S. system). I.V. steroids are indicated in cerebral 
malaria (e.g .• dexamethasone 4-6 mg. being administered every 4-6 hours). 
Intravascular coagulation may occur with cerebral ·malaria. 
P.falciparum malaria-resistant to chloroquine. 
1. Where the attack is not severe. - Adults are given; 
Oral quinine sulfate - 650.mg. t.i.d. for 14 days-plus; 
Oral pyrimethamine - 25 mg. b.i.d. for 3·days - plus; 
Oral sulfadiazine - 500 mg. q.i.d. for 5 days 
(or oral dapsone, 25 mg. daily for 28 days can be used instead of sulfadiazine). 
Where the patient is severely ill the following is given; 
Quinine·dihydrochloride - 600 mg.in 300 ml. normal saline, given intravenously 
slowly over half an hou_r. Dose is repeated after 8 hours. As soon possible oral 
therapy is substituted. 
Other drugs have been used to treat the drug-resistant parasite e.g. 
sulformethoxine a single dose of 1.0 mg. being given with.a single dose of pyrime-
thamine 50 mg. Tetracyclines and trimethoprim have also been tried. 
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CHAPTER 4. 
THE PATIENT WITH DIARRHEA - ? AMEBIC INFECTION. 
Diarrhea ranks high-on the list of symptoms for which the traveller seeks 
medical aid on his return froin_the tropics, and this complaint can be the. 
presenting symptom in a wide range of tropical maladies. Advice is usually 
sought because the bowel upset persists or recurs at frequent periods after 
the return from the tropics. Although one can distinguish between diarrhea and 
dysentery (diarrhea plus blood and.mucus) such a distinction is often academic. . . . 
Amebic infections are not the commonest cause of diarr.hea in these subjects, but 
the condition should receive some extr.a attention, for_ if untreated the 
infection can have grave sequelae. In orde_r .that no parasitic dis_ease is over-
looked in the patient with diarrhea, the physician should adopt a systematic 
approach consisting of; 
1. HISTORY. -UNDE VENIS? 
2. PHYSICAL EXAMINATION. 
3. FRESH STOOL.EXAMINATION . 
. 4. OTHER INVESTIGATIONS. 
The history is useful, for although no one geographical area can claim the 
monopoly on any given parasitic disease,_ the travellers itinary may indicate 
some possible culprits. Although it is a some.what grandiose assumption, it is 
a safe rule to. regard a 11 subjects who have returned from the tropics and who 
give a history of bloody diarrhea accompanied by abdominal cramps after visiting 
such countries as India, Vietnam, Phillipines and areas of South America and 
·tropical Africa, as having an amebic infection until proved otherw.ise~ It is 
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useful to know if the subject took prophyl_actic drugs for compounds such as 
iodochlorhydroxyquinmay mask amebic infections. Occasionally early schistosomiasis 
can produce diarrhea and ther.e might be a hi story of swimming in fresh water. In 
all instances it must be ascertained whether the individual had any previous history 
of diarrhea before going to the tropics, for such condftions as ulcerative colitis 
have a high risk of relapse in tropical climates and of_ course in all cases it is 
essential to· rule out other causes-of diarrhea, for parasitic infections may co-exist 
with a wide range of other diseases. (e.g, neoplasms). 
A physical examination has little chance of pin-pointing the exact cause 
of any diarrhea in these subjects, but sometimes it yields suggestive clues. Thus 
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WHERE INDICATED. - X-RAY INVESTIGATIONS/INTESTINAL BIOPSY/MALABSORPTION 
STUDIES/LIVER SCAN (HEPATIC ABSCESS)/ETC.) 
SIGMOIDOSCOPY AND OTHER INVESTIGATIONS ARE ALSO INDICATED TO ELIMINATE 
"NON-TROPICAL" CAUSES (e.g. NEOPLASMAS OR .ULCERATIVE COLITIS). 
infections may be associated with tenderness over the hepatic area (amebic liver 
'"abscess): Falciparum-malaria sometimes produces a watery diarrhea and the presence 
of splenomegaly would support this diagnosis. 
A thorough examination of the stools must be. done. At least 3. FRESH samples 
should be obtainep i.e. the sample should be examined at the laboratory and 
this should be done immediately after the stool have been passed. If this .is not 
feasible then the samples must reach the laboratory within one hour after being 
passed. Often patients do not take kindly to the prospect of producing several 
fecal samples, but they must be told that a single negative report does not 
rule out parasitic infection. Preserved stool samples are very much a second best 
proceedure. 
In all cases bact~riological studies should be carried out, par~i~ularly to 
rule out shigella and salmonella infections. Occasionally culture methods are 
useful in isolating amebic infections. 
Sigmoidoscopy is useful in confirming amebic infections.and radiological 
examination of th~·gastrointestinal tract may reveal other causes of diarrhea 
such· as ulcerative colitis. Long standing giardiasis can produce malabsorption 
syndromes and in some travellers, particularly "overlanders" malabsorption 
syndromes may be found in the absence of any parasites. In these subjects fat, 
xylose and vitamin B 12 malabsorption is present and low levels of serum fol ate 
and vitamin B 12 confirm the diagnosis. Sometimes inte~nal biopsy methods are 
.used to confirm such disease as schistosomiasis or malabsorption. On occasions 
blood culture and serological techniques are of· use e.g. in the diagnosis of typhoid. 
Radiological investigations are often needed, especially to exclude non-parasitic 
causes of diarrhea. 
AMEBIASIS. 
Entameba histolytica usually exists in the large bowel, as a commensal, but 
it is capable of.invad~ng the bowel wall and spreading to other organs. In some 
tropical areas over three-quarters.of the population harbour the parasite. 
TRANSMISSION - Humans become infected by swallowing the cysts of the par:asite. 
CLINICAL FEATURES~- The incubation peridd i-s often long, and symptoms can occur 
many years after the initial exposure. In most instances the onset is insidious, 
and the main complaints are of abdominal discomfort and diarrhea (with or without 
blood and mucus). In more severe cases tenderness over the sigmoid colon is found 
and there may be 10•12 stools/day, accompanied by abdominal cramps. Pyrexia is 











appearing in several different forms, and the W.H.O. classification is useful. 
l. Asymptomatic. 









Many subjects who excrete the cysts remain symptomless i.e. the presence of cysts 
in the stools is not synonymous with ame9ic disease. 
COMPLICATIONS. (of intestinal amebiasis). 




5. Abscess formation. 
DIAGNOSIS. 
1. History of diarrhea, .abdominal cramps, blood and mucus in the stools. 
2. Acute stage - the motile trophozoites of Entameba histolytica are found.in 
a FRESH stool sample. 
3. In the chronic stage the diagnosis. is made by observing the cysts in the stools. 
4. Culture methods are also available, but they are not reliable for. routine use. 
5. Endoscopy may reveal the characteristic ulcers associated with this parasite, 
and this can be combined with a biopsy. 
6. Serological methods are available (e.g. Indirect hemagglutination test, 
complement fixation test and indirect fluorescent antibody test). 
DIFFERENTIAL DIAGNOSIS. 
1. Bacillary.dysentery. 
2. Ulcerative colitis. 
3. Diverticulitis. 
4. Giardiasis. 
5. Tropical sprue. 
6. Balantidiosis. 
7. Intestinal TB. 
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AMEBIC LIVER ABSCESS. 
The commonest extraintestinal form of the disease is hepatic involvement, 
and this can present many years after the original exposure .with such varied 
symptoms as pyrexia, abdominal discomfort, general malaise and pain over the 
right costal margin. There may be a leucocytosis and increased sedimentation 
rate. Liver function tests are not usually affected. Clinical examination 
sometimes reveals a tender enlarged liver. To confirm the diagnosis a liver scan,. 
screening ·of the diaphragm. and serological tests for extraintestinal· amebiasis 
are often required. X-ray examination is used to demonstrate elevation of the 
~ight diaphragm. 
TREATMENT OF AMEBIC INFECTIONS. 
1. Patient who passes cysts, but has no symptoms. (Adult doses) 
Diibdohydroxyquin - given orally. 650 mg. t.i.d. for 20 days 
(This drug should be given with care because of the risk of optic neuritis). 
or; 
Metronidazole - given orally. 750.mg. t.i.d. for 7-10 days 
or;· 
Diloxanide furoate - given orally. 500 nig. t. i .d. for 10 days. 
2. Patient with intestinal disease (not severe). 
Metronidazole - given orally. 750 mg. t.i.d. for 7-10 days. 
3. Patient with intestinal disease (severe). 
Metronidazole (as in 2). 
or; 
Dehydroemetine - I.0-1.5 mg./kg. daily. Given intramuscularly or subcutaneously 
for up to 5 days. 
N.B. With reference to the above it should be noted that;. 
A. Originally metronidazole was considered to be effective at ali sites of amebic 
infection, but _recent evidence suggests that amebic liver abscesses can develop 
when metronidazole is used alone to treat the intestinal form of the disease. 
However many still consider this compound to be the drug of choice. 
B. Emetine and its derivatives can have highly toxic effects on the cardiovascular 
·system, and such drugs should only be given-to subjects who are hospitalized. 
Patients should have regular electrocardiographic monitoring during therapy. 
Other drugs have also been used for the treatment of amebiasis including 




4. Treatment of amebic liver abscess. 
Larger abscesses may require surgical drainage. Drugs used include. 
Metr.anidazole - given orally. 750 mg. t. i .d. for 7-10 days 
or; 
Dehydroemetine·- l.0-1.5 mg./kg. daily. Given intramuscularly or subcutaneously 
for up to 5 days. 
Pl us; 
Chloroquine. phosphate. Given orally - 1.0 gm. daily for.2 days then 500 6g. 
daily for 21 days. 
N.B. All patients who have been trea.ted for intestinal amebiasis should have 
follow-up stool examinations for one year. 
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AMEBIASIS-CLINICAL FEATURES 
A.~BIC DYSENTERY -~ 
INSIDIOUS ONSET · 
LOXG INCUBATION PERIOD" 















RuPTURE OF ABSCESS 
CHAPTER 5 
"P.U.0. 11 I EOSINOPHILIA/OVERLANDER SYNDROME. 
Sometimes subjects returning from the tropics state that they feel we 11 
except for periodic bouts of fever, and in all these cases after it has been 
ascertained that none of the "usual" causes of fever are present then one is 
left with· a list of. "tropical" entities which may present as a P.U.O. 
IF ANY SUBJECT WITH A PYREXIA, OR HISTORY OF PYREXIA, HAS RETURNED FROM A 
·MALARIOUS AREA, THEN THE PHYSICIAN SHOULD ASSUME MALARIA TO BE PRESENT UNTIL 
PROVED OTHERWISE. 
Often the zone visited provides a clue to the likely causes, Thus with 
reference to U.S.A. troops in South Vietnam the following diseases were found to 
be common causes of pyrexia; malaria, leptospirosis, typhus and arbovirus infections . 
(including dengue and Japanese B encephalitis)r 
1. HISTORY-UNDE VENIS? 
2. PHYSICAL EXAMINATION. 
3. EXAMINATION OF FRESH STOOL SAMPLES. 
4. BLOOD FILM EXAMINATION. 
5. OTHER INVESTIGATIONS. 
Did you take antimalarials as directed? Where did you travel? Did you 
swim in fresh water? Did you have all the· recommended prophylactic immunizations 
before travelling? These are some of the main questions to be directed at all 
who admit to#1Jisodes of pyrexia after returning from tropical climates. As has 
been.mentioned even though antimalarial drugs were taken correctly, malaria can 
still be present. The physical examin.ation sometimes yields a pointer to the etio-
logy of· any unexplained fever. Thus typhoid produces a typical rash. Possible 
jaundice should be looked.for.Splenomegaly and fever would raise the possibility of 
such infections as malaria, typhoid or leishmaniasis being present. 
Hepatomegaly is associated with hepatitis, malaria, leishmaniasis or amebic 
liverabscess_. Fresh stool samples must be. examined for ova and. parasites to exclude 
conditions such as amebiasis and bacteriological culture studies are required to 
detect bacillary dysentery and typhoid. Urinalysis may reveal the eggs.of 
schistosomiasis·(S.hematobium). 
Malaria, trypanosomiasis or filariasis can be detected on a suitable blood 
film, and an eosinophilia would lead one to suspect the presence of some parasitic 
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disease. Blood cultures are useful (typhoid and brucellosis) and marrow samples 
may reveal leishmaniasis. Serological tests are useful in confirming some ·infections 
e.g. Widal test, Weil-Felix reactions, the various complement-fixation reactions 
(e.g. trichinosis and filariasis), and other tests (e.g. latex agglutinatination 
·test for extraintestinal amebiasis-Serameba.test). Liver function investigations 
would confirm the presence of hepatitis. Intradermal sensitivity tests are also 
available for brucellosis, lymphopathia venereum (Frei test), and hydatid disease 
as well as other infections. Tuberculosis must never be forgotten and all subjects 
are advised to have a chest X-ray on returning from the tropics. 
Radiological techniques are also of use for other infections e.g. I.V.P. invest-
iga~ion can sometimes reveal genito-urinary schistosomiasis, screening of the 
diaphragm may reveal abnormalities due to amebic liver abscess and liver scans 
are taken to .confirm the presence of such abscesses. 
The following are some of the causes of fever to be considered in subjects 
returning from abroad. 
(Points relating to diagnosis are given in parenthesis). 
1. MALARIA. (Blood films-thick and thin/bone marrow/fluorescent antibody). 
2. AMEBIASIS. (Stools/Sigmoidoscopy/Serology.-Liver abscess-Liver Scan/X-ray). 
3. BACILL:.~Y DYSENTERY. (Stools). 
4. TYPHOID. (Serology/Blood & Stool culture/Urine culture). 
5. FILARIASIS. (Blood films-day & night/Serology). 
6. SCHISTGSOMIASIS. (Stools/Urine/I. V. P ./Biopsy/Serology). 
7. TRICHINOSIS. (Muscle Biopsy/X-ray/Serology/Skin tests). 
8. HEPATITIS. (Liver Function Tests). 
9. BRUCELLOSIS. (Blood culture/Serology). 
10. TYPHUS. {Weil-Felix). 
11. TUBERCULOSIS. (X-ray). 
12. ARBOVIRUSES. (e.g. Dengue/Yell ow< Fever). 
13. TRYPA~OSOXlASIS. (Blood films/Lymph node smears/Cultures/Serology). 
14. LEISHl"'.ANI.l\SIS. (Blood films/Bone marrow/Splenic puncture/Cultures/Serology). 
15. LASSA FE'IER. -rare (Serology). 
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"PALM TREE" P.U.O . .._. . .. 
ALWAYS RULE OUT "EVERDAY" CAUSES. (e.g. urinary tract infections). ·. 
ALWAYS RULE OUT MALARIA. 




































"EOSINOPHILIA" - ON RETURN FROM THE TROPICS AND THE "OVERLANDER" SYNDROME. 
A. EOSINOPHILIA. 
Sometimes a-routine physical examination in patients who have returned from 
the tropics reveals no significant abnormality, the subject states that they 
feel to be in good health, but laboratory tests reveal a single isolated abnormality 
and the physician is left to decide whether further investigation is warranted. 
One such example is the patient who is found to have a persistent eosinophilia, 
and this finding ALWAYS merits an extensive search for parasitic disease. 
Potential parasites and conditions to be cpnsidered in such cases are listed below, 
but is should be remembered that not all of these infections are found in all 







6. LARVA .MIGRANS. 
7. STRONGYLOIDES. 
8. TROPICAL EOSINOPHILIA. 
Filariasis can sometimes be difficult to diagnose, particular as "occult" 
forms can occur. The microfilariae of W. bancrofti show a nocturnal period-
icity (appearing in the blood between 10 p.m. and-2 a.m.). The infection 
is found in such areas as tropical Africa, West Indies, South America and some 
South Pacific zones _(where the microfilariae may appear in the blood in the 
day and at night) and parts of Asia. The microfilariae of B. malayi also show 
nocturnal periodicity and the parasite is found in Indonesia, Malaysia, parts 
of China and India and the clinical picture is similar to that of W. bancrofti. 
The filarial worm Loa loa occurs in well defined zones in tropical Africa and 
the microfilariae appear in the blood in ~he largest numbers.in the day. The 
eosinophilia can be very high {up to 90%). Occasionally the adult-worm is to be 
observed crossing the eyelid or conjunctiva. The filarial worm Onchocerca volvulus 
can produce subcutaneous nodules and the parasite is present in tropical Africa 
and South America. The eye lesions are the main danger from the worm but mainly 









are found in the skin nodules. Suitable blood films remain the.main diagnostic 
test for filariasis, but intradermal, complement fixation tests and other serological 
tests are also used~ 
With reference to schistosomiasis, the history may show that the traveller 
spent some time in a endemic region and indulged in fresh water swimming. In 
S. hematobium infections the diagnosis is confirmed by finding the eggs of the 
parasite in the urine and the subject often admi.ts to painless hematuria. In 
some cases an I. V. P. demonstrates involvement of the urinary tract. S. mansoni 
and S. japoni cum infections are confirmed by observii1g the eggs of the fluke 
in the stools. Rectal mucosal biopsy is also used. Intradermal and vario~s 
serological tests are available for the detection of filariasis. Ascariasis 
is capable of producing a high eosinophilia, and is confirmed by finding the ova 
of the worm in a stool sample. Ancylostomiasis is common in tropical countries 
and can remain symptomless, but examinat_ion of the blood often shows an eosinophilia 
to be present and sometimes there is evidence of an iron-deficiency anemia. 
Diagnosis is by finding the eggs of the hookworm in suitable fecal preparations. 
Trichinosis is associated with high eosinophil counts, but it should be noted that 
stool examinations are only helpful in the.early stage of the infection and 
diagnosis·usually depends upon muscle biopsy, X-ray examinations (?calcification 
in soft tissues), intradermal tests and serol~gical investigations. The persistent 
eosinophilia of visceral larva migrans (v. l.m.) on occasions is accompanied by 
such clinical firiding as hepatomegaly, asthma-like syndromes and pyrexia and a 
similar pulmo~i.ltY picture can be observed in- strongyloides infections where the 
presence of the nematode is confirmed by finding the adult worm or larvae in the 
stools . .In tropical pulmonary eosinophilia there may be fever, spleriomegaly, 
cough, hemoptysis and ill-defined mottling on chest X-ray films. It is 
·present in such areas as Sri Lanka, India and Malaysia and is probably a reaction 
to the incomplete maturation of a filarial worm, for often the sydrome yields 
positive serological tests for filariasis, yet no lliicrofilariae are to be observed 
in the blood and the symtoms respond to diethylcarbamazine. 
THE OVERLANDER SYNDROME. 
This entity has been well described by Knight and is of particular interest 
to the physician who sees students on their return from the tropics. The syndrome 
usually relates to the· 18-25 year old traveller whose journey lasts from some 12 
week to 2 years and takes in such areas as India, Turkey, Afghanistan and various 
parts of Europe. Many of these subjects now travel across the. various exotic 
areas of South and Central America. Often the going is rough and for financial 
considerations the diet is poor and the life style adopted brings the visitor into 
contact with many potential hazards. On their return these patients commonly give 
a history of loss of weight, general malaise and diarrhea, and although the 
diarrhea is often due to Shigella organisms, the possibility of other parasites 
being present must never be ignored. Amebic infections, giardiasis and hepatitis 
are by no means rare in the overlander and where recurrent or persistent diarrhea 
is present the following possibilities must be kept in mind; 
1. Amebic dysentery. 
2. Giardiasis. 
3. Bacillary dysentery. 
4. Tropical sprue. 
5. Various other parasites-especially ascaris, trichuris trichuria, hookworm 
and strongyloides. 
Amebic infections may be masked by the self-medication which the overlander 
takes as a panacea. Giardiasis is sometimes associated with vague abdominal 
discomfort, anorexia and malabsorption syndromes. Trppical sprue is not common 
but can sometimes be observed in subjects who have spent time in India or 
Sourth-east Asia and who complain of diarrhea, malaise, loss of weight and 
glossitis. Vague abdominal symptoms are common in the overlander and are often 
functional, but repeated fresh stool examinations must always be carried out to 
exclude parasitic infections. Tomkins has recently described 34 cases of mala-
bsorption in a group of overlanders going to India and symptoms included 
diarrhea, abdominal distension and weight loss. Investigations revealed fat, 
xylose and Vitamin Bl2 malabsorption with mucosal changes. Low levels of .serum 
folate and Vitamin Bl2 were seen in those with long standing diarrhea, but no 
anemia was observed. Most subjects responded to a course of tetracyclines for 
two weeks follol'led by sulfadimidfoe for two weeks. Most subjects. also received 
folic acid. 
Viral hepatitis remains a constant threat to the overlander in his travels, 
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and abnormal liver function tests are not rare. One of the paradoxes of the syndrome 
is that although many of the subjects wander through malarious zones, few develop 
overt malaria •.. even though antimalarials were not taken. Fungal skin infections, 
various· ectoparasites and V.D. are not uncommon in this group of global travellers. 
PERSISTENT EOSINOPHILIA~PARASITES PROBABLY PRESENT. 
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CHAPTER.6 
WOBBLY WORMS 
Most Family Physicians are.now seeing an increasing number of "imported" 
diseases, and often a routine investigation (e.g. a stool examination done for 
immigration purposes) will reveal the presence of some unsuspected parasite. 
The following notes relate to some of the helminthic infections which are essent-
ially detected by fecal examinations •. Some infections (e.g. ascaris, tapeworms 
and pinworms) are by no means rare in subjects who have never been in the tropics. 
The physician interested in seeking out the various worms which trouble the human 
host should keep the following points in mind. 
l. In all cases it is_mandatory to make a positive identification of the worm be-
fore treatment is initiated. Fresh stool examination yield the richest 
harvest and tests involving preserved samples are very much a second best. 
Unfortunately a "negative" result does not mean too much as far as the average 
commercial laboratory is concerned, and facilitites for the efficient diagnosis 
of parasitic disease are sadly lacking in most areas. 
2. Because of the potential adverse reactions involved, antihelminthic drugs 
should not be used in the pregnant subject. 
3. Serological and skin tests are available for the detection of some worms, 
but as far as the family Physician is concerned, such investigations are best 
carried out in.tropical disease clinics or similar units. 
(The National Reference Centre for Parasitology, Montreal, carries out a 
wide range of tests for parasitic disease). 
4. After therapy it is essential to perform follow-up investigations before the 
patient can be pronounced "cured". 
l. ASCARIS (Roundworm). 
Ascaris lumbricoides lives in the small intestine. Infections due to the 
worm are widespread throughout the world and. some say that I in every 4 of the 
human race is host to the helminth. The parasite is acquired by ingestion of the 
fertile eggs and food and drink are the common vehicles involved. ·uften there 
are no symptoms, but the migration of larvae in the early stages of the infect'ion 
is sometimes-associated with pulmonary signs (Loefflers syndrome consists of the 
pulmonary manifestations, eosinophilia and adenitis). The adult worms may 
produce pruritus ani, 1ntestinal colic, acute appendicitis, and occasionally there 




convulsions or epilepsy. Some patients "vomit" the worm. Diagnosis is dependent 
upon observing the ova or adult worms in the stools. An eosinophilia supports the 
diagnosis and occasionally ~he helminth ~ay be detected in barium meal examinations. 
With reference to therapy it should be stressed that where mixed _infections 
occur, ascaris must always be treated first. Piperazines are the drugs of choice. 
Piperazine citrate. (Antepar). 
Given orally· (syrup). 
Up to 30 lb. of B.W. - 1.0 gm. for 2 consecutive days. 
30-50 lb. of B.W. - 2.0 gm. for 2 consecutive days. 
50-100 lb. of B.W. - 3.0 gm. for 2 consecutive days. 
Over 100 lb. of B.W. - 3.5 gm. for 2 consecutive days (maximum daily dose). 
Piperazines are usually well tolerated but are contraindicated in those with 
a history of seizures or renal dysfunction. Adverse effects include dizziness, 
tremors, vomiting and skiil rashes. 
Pyrantel pamoate (Combantrin) can also be used. (Not in those below the age 
of one year). A single oral dose is administered. (As suspension or tablets).· 
DOSE. (per B.W.) 
11 Kg. or less - 125 mg. 
11 Kg. - 22 Kg. - 250 mg. 
22 Kg. - 45 Kg. - 500 mg. 
45 Kg. - 70 Kg. - 750 mg. 
Over 70 Kg. body weight - 1000 mg. (maximum daily dose). 
Potential adverse drug effects indlude vomiting, headache and dizziness. 
2. HOOKWORM (Ancylostomiasis). 
The nematodes Ancylostoma duodenale and Necator americanus live in the 
human small intestine (mainly_in the jejunum). The larvae enter the human host 
via the skin, and·the infection is usually acquired by walking barefoot on 
contaminated soil. An itchy dermatitis sometimes appears at the site of entry of 
the larvae and migration of the larvae through the pulmonary tissues is associated 
with eosinophilia, asthma and blood-stained sputum in some subjects. A clinical 
history of a short unexplained episode of asthma in a patient returning from the 
tropics would ·raise the possibility of a helminthic infection being present. The 
main pathological effects depend upon the worm load and often there are no clinical 
symptoms, but heavy infections result in anemia (iron-deficiency type) and 
epigastric discomfort (mimicking an ulcer). Eosinophilia is common. 
Diagnosis rests upon detecting the eggs of the worm in.the stools, and therapy 
·.consists of administering an antihelminthic drug and correcting any anemia which 
is present. The drug of choice is Pyrantel Pamoate (but not given to children 
under theage of l year). ForA. duodenale infections a single oral dose is given 
{in the same amounts as for ascaris). For N. americanus infections the same 
daily doses are used but the drug is given for 3 consecutive days. ·Bephenium 
hydroxynaphthoate (Alcopar) may tie used as an alternative drug. 
A. duodenale infections-Adults and children over 2 years of age are given an 
oral dose of one 5 gm. sachet b.i.d. for l day. 
Children under 2 years of age or under 10 Kg. in body we.ight should receive half 
the above dose. 
N. americanus infections-the above doses are given daily for 3 consecutive days. 
The drug·is best taken on an empty stomach and food should b~ with held for 2 hours· 
after taking the drug. The preparation must be given with care to hypertensive 
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patients but is usually well tolerated. Adverse reactions include vomiting and diarrhea. 
Thiabendazole {Mintezol) has also been tried in ancylostomiasis. The tablets are 
given orally .at· a dose of 25 mg./Kg. of body weight b.i.d for 2 days (given after 
food). The maximum daily dose is 3 gm. Adverse effects include headache, 
dizziness, vomiting, drowsiness and leucopenia. 
J. STRONGYLO!DES. 
·The nematode Strongyloides stercoralis usually infects the small intestine. 
Most infections are symptomless. The larvae enter the skin and are carried to 
the lungs where they are sometimes associated with pulmonary signs and symptoms • 
. Other clinical features include diarrhea, eosinophilia and skin rashes (creeping 
eruptions and urticaria). Debilitated subjects have been known to succumb to 
"massive" infections with the worm. Diagnosis is by finding the adult or larval 
forms of the nematode in. the stools or in a duodenal drainage specimen. 
Treatment is with Thiabendazole (given in the same doses as for hookworm 
infeCtionsr. 
Pyrvinium Pamoate (Vanquin) has also been used at an oral dose of 5 mg./Kg. of 
body weight; given for .5-7 days. {maximum daily dose being 250 mg). 
The dru·g should not be given to children under l year of age. Pyrvinium pamoate 
stains the stools red. It should be noted that ir. Canada the indications for use 
of the drug do not include strongyloides. 
4. TRICHURIASIS. (Whipworm). 
Trichuris trichiura infects the cecum and colon and infection occurs through 
ingestion of the embryonated eggs (from contaminated soil). Usually there are no 
symptoms, but diarrhea, blood in the stools or rectal prolapse (in children) 
are manifestations of heavy infections. The presence of the eggs of the worni in 
the stools confirms the diagnosis. The drug of choice is Mebendazole. The 
drug is very well tolerated, but should not be given to children below the age of 
2 years. For other subjects the dose is; Mebendazole-given orally-100 mg b.i.d. 
for 3 days. 
Thiabendazole can also be used but it is not always effective in trichuriasis. 
The oral dose is that used for hookworm infections. 
5. - CLONORCHIS. (Clonorchis sinensis) 
This liver fluke is essentially found in the Far East (Japan, China a_nd Korea). 
It is acquired by consuming raw contaminated fish. Often the worm produces no 
symptoms, but fever, jaundice and choloangitis are occasionally_present. The 
parasite has also been associated with adenocarcinoma of the liver. As with many 
other helminthic infections ectopic larvae can produce damage in-a wide range of 
tissues (e.g. in the C.NS. and lungs-). The typical eggs of the parasite can be 
seen in the stools or on examination of aspirates of duodenal contents. Therapy 
is unsatisfactory. Oral doses of Chloroquine phosphate (250 mg. t.i.d. for 6 
weeks in adults) may diminish egg production by the fluke, but the drug has 
significant adverse effects and dose not kill the worm.- Bithionol, Dehydroemetine 
and Emetine are other preparations which have been given for the parasite, but 
none is_ completely satisfactory. 
6. SCHISTOSOMIASIS. (Blood Flukes). 
The therapy of these trematodes is best carried out at a Tropical Disease 
Unit and as the worm produces a wide variety of pathological and clinical changes, 
only a ·few brief details are covered here. 
_ S. hematobitim (Lives in the veins of the bladder)-~s found in Africa and the 
-Middle East. A few other foci also occur. 
S. mansoni (lives; in the veins of the mesentery)-is found in Africa, Middle 
East. S. America and the Caribbean. 
S. japonicum (lives in the veins of the small intestine)-is found in the Far_ East. 
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Infection is acquired in endemic zones by swimming in contaminated fresh 
water. Clinical features include skin rashes (early stages), fever, eosinophilia, 
dysentery,hematuria (S. hematobium), hepatic damage and C._N.S. involvement. Genito-
urinary symptoms predominate in S. hematobium infections. S. mansoni may be 
associated with intestinal signs and symtoms. Severe infections may mimic a carci-
noma and polypi are sometimes present. Late stages lead to hepatic fibrosis and 
portal hypertension. S. japonicum produces a similar clinical picture. The Katayama 
syndrome may be present in S. mansoni and S. japonicum infections (fever/skin 
rash/eosinophilia/cough). For the diagnosis of S. ·hematobium the eggs of. the fluke 
should be sought for.in the urine (terminal portion), feces or biopsy (bladder/ 
rectum~. I.V.P. and cystoscopy are us~ful. For S~ mansoni and S. japonicum_the 
-eggs may be present in the stools or in biopsies of intestini or rectum. Serol-
ogical and skin tests are also available. 
Niridazole (Ambilhar) has been used for S. hematobium and S.mansoni infections. 
(at present the drug is only available from special units). 
Dose: An oral dose of 25 mg./Kg. of B.W./day (Maximum 1.5 mg.) is given for 
5-7 days. 
Adverse effects include dizziness, mental changes, seizures, vomiting, E.C.G. 
changes, skin rashes and hemolysis (G-6-PD deficiences).The drug should not be 
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used where there is hepatic dysfunction, portal hypertension or a history of seizures. 
Some prefer the use of Stibophen for S. mansoni infections. S~ japonicum is . 
difficult to eradicate and·Antimony Potassium Tartrate has been used. 
7. TAPEWORMS. 
A. TAENIA SAGINATA (Beef tapeworm). 
This cestode has a worldwide distribution and humans become infected by.eating 
raw beef (a delico.cy with a fair number of Canadians). Most subjects have no 
symptoms, but abdominal pain, vomiting and the observation of proglottides around 
the anus may be a feature of the infection. Diagnosis is by finding the eggs or 
proglottides in the stools. The drug of choice is Niclosamide (Yomesan). but the 
drug should not be given to children under the age of. 2 years. 
DOSE-adults and chit dre:n over the age of 6 years-a single ora 1 dose of 2 gm. is 
given. Children between the ages of 2 and 6 years are given 1 gm .. The drug should 
be taken after a light meal. The tablets should be chewed before being taken with 
water. Adverse reactions are rare (mainly gastrointestinal). 
Mepacrine has also been used. 
. ; 
I 
B. TAENIA SOLIUM. (Pork ·Tapeworm). 
This is acquired by eating raw or poorly cooked pork. The adult worm gives 
a similar picture to the beef tapeworm as far as the clinical picture is 
concerned. However the cysticerci may cause lesions in a wide range of tissues, 
and treatment is only symtomatic. The tapeworm is detected by detecting the ova 
.in the stools. Niclosamide is used to treat the tapeworm infection, but is not 
without danger. (risk of auto-infection). The dosage is the same as that mentioned 
for the beef tapeworm, but in order to lesson the risk of causing cysticercosis, 
a purgative should be given 2 hours after the drug is taken. 
C. DIPHYLLOBOTHRIUM (Fish tapeworm). 
Man is infected by eating raw contaminated fish. It usually produces little 
in the way of symptoms, but can be associated with a Bl2 vitamin deficiency 
(megaloblastic anemia). Niclosamide is the drug of choice (same doses as for the 
other tapeworms). 
D. DWARF TAPEWORM 
The small tapeworm, Hymenolepis nana, rarely gives clinical signs or symptoms. 
Treatment is with Niclosamide. 
Dose-Adults and children over 6 years of age-2 gm. on the first day, then 1 gm. 
daily for 6 days. Children between the ages of 2 and 6 years should be given 1 gm. 
on the first day and then 0.5 gm. daily for 6 days. For good results a second 
course can be given 3 week after the above therapy. 
8. PINWORM (Enterobiasis). 
This ubiquitous parasite is the corrunonest helminth with the worst "therapeutic" 
record. It is difficult to eradicate and occurs in all members of a family. 
Clinical features include pruritus ani, vulvitis, insomnia and enuresis. Di.agnosis 
is bY perianal swab. Mothers may observe migration of the worms (perianal) in 
their children at night. All the family should be treated. General hygiene is 
important (particularly to remove eggs from under the finger nails). Pyrantel 
pamoate is the drug of choice. Given orally as a single dose, the dosage is the 
same as that used for ascaris, and the same precaution should be observed. The 
dose should be repeated after 2 weeks. 
Or Piperazine citrate can be given~ 
Daily dose - Up to 15 lb. of B.W. - 250 mg. 
15 - 30 lb. of B.W. - 500 mg. 
30 - 60 lb. of B.W. - 1 gm. 
Over 60 lb. B.W. & Adults - 2 gm. 
The drug is given for 7 days, withheld for 7 days and then given for another 7 days 
43. 
Pyrvinium pamoate is also used. 
Dose-single oral dose of 50 mg./22 lb. B. W. This can be repeated after 2 weeks. 
In summary the family physician can expect to see an increasing number of 
patients who are hosts to an unwanted helminth. A good medical history will 
help to narrow down the list of possible culprits (Unde venis-Where have you 
been?/What have you eaten?). Good follow-up is essential, and it is worth mention-
ing that fact that post-therapy stool examinations should not be carried out 
straight after drug therapy as residual eggs of the worm will be present for 
some time after the cess~tion of therapy. 
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CHAPTER 7 
NOTES ON SOME TROPICAL DISEASES. 
(For notes on helminthic infections:please see previous section on wonns). 
BALANTIDIOSIS. 
This is relatively rare but on occasions may produce severe dysentery. 
Infection is acquired by ingesting the cysts {passed in the feces of pigs). In 
·the acute case the parasite is found in the stools, but in chronic infections 
.the cysts are present in the stools. Tetracyclines are effective therapy. 
CHOLERA. 
An acute infection due to the Vibrio cholerae presenting clinical1y with 
vomiting, cramps and watery diarrhea. Water or food are usually involved in the 
transmission of the disease. Incubation period is about 3-6 days and the vaccine 
does not offer total protection against the disease. Dehydration and shock are 
the main risks. Diagnosis is by finding the organism in the stools. El Tor 
cholera has been seen in many countries. Treatment is directed to correcting the 
dehydration and shock and correction of electrolyte imbalance 
and the.administration of a suitable antibiotic (e.g. Tetracyclines for 
3-5 days). At least three stool samples should be negative before the patient is 
declared free from the infection. Immunity, by vaccination lasts for some 3-4 
months. 
DENGUE FEVER. 
This arbovirus has been associated with fever, rashes, muscle pains and 
hemorrhagic syndromes (which have a high death rate). The incubation period is 
5-10 days. Treatment is essentially symptomatic. 
DRACONTIASIS. 
The guinea-worm is found in India and Africa. The infection is transmitted 
.through water, via Cyclops. The female worm usually inhabits the connective 
tissues of the trunk and limbs. In over three-quarters of the cases the lower 
extremities are involved, the patient complaining of discomfort and blistering. 
Treatment involves extraction of the parasite and Hetrazan and Niridazole have 
also been used. 
FILARIASIS. 
Several nematodes of the family Filariidae are associated with human.disease. 
The parasite is transmitted by the bite of infected insects (e.g. mosquitoes & 
Black flies) the adult worms.usually inhabit the lymphatic tissues, skin or 
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connective-tissues. Incubation periods are long (up to 12 months or longer) ·and 
the short-stay visitor is not commonly affected. 
A. Wucheria bancrofti. 
This is found in many areas including tropical Africa, Asia, South America 
and some South Pacific zones. The ·adult worms usually lie in the lymphatic tissues, 
and the microfilariae can -be observed in the peripheral blood at night (10 p.m.-
2 a.m.). Light infections are often symptomless but heavier.ones may produce 
interference with lymph flow. Clinical presentations include pyrexia, lymphangitis 
and elephantiasis. Diagnosis is confirmed by detecting the microfilariae in suit-
able blood films. Complement-fixation and intradermal tests are also useful. 
There is often·an associated eosinophilia. Diethylcarbamazine is used to treat 
the condition, but must be given with care because of the risk of acute "allergic" 
reaction. 
B. Brugia maiayi. 
This worm is present in such areas as China, Malaysia and Sri Lanka. 
Essentially it resembles W. bancrofti infections. Diagnosis is by detecting the 
microfilariae in the peripheral blood (these may be nocturnal or present in the 
day). Treatment. is wi_th diethylcarbamazine. 
C. Loa 1 oa. 
Loa loa is confined to West and Central Africa. The adult worm lives in the 
subcutaneous tissues. Clinical features include Calabar swellings (transitory 
edematous swellings in the skin), fever, eosinophilia and occasionally the 
movement of the w:irm in the skin or across the eye may be noticed. Diagnosis 
is by the detection of the microfilariae in the blood (day time sample). Treatment 
is with diethylcarbamazine. 
D. Onchocerciasis. 
This is found in t;·opi ca 1 Africa, and parts of Centra 1 and South America. 
It is transu.itted by flies of the genus Simulium. Clinical features include 
subcutaneous nodules (which contai
0
n the adult worm), skin rashes· and eye lesions 
which remain the most dreaded complication.of the disease, for these may lead to 
blindness. The conjunctiva may be involved and chronic iritis and cataract can 
develop. Diagnosis is by biopsy of the nodules. Microfilariae are sometimes seen 
in skin samples and occasionally in the anterior chamber of the eye. A high 
eosinophilia can be present. Diethylcarbamazine is effective but there is a risk 
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of allergic eye reactions, and the drug is best given with concomitant antihist-· 
·amines or steroids .. Other drugs have also been used e.g. Suramin. 
GIARDIASIS. 
Although this-parasite is present throughout the world (it has recently been 
in the public eye after a good number of visitors to Russia became infected with 
it), it is commonly seen in visitors returning from the tropics and clinical 
features include abdominal discomfort, flatulence, diarrhea and malabsorption 
·syndromes. It is common in overlanders. Giardia lamblia inhabits the upper 
part of the sma.ll intestine and duodenum and humans are infected by ingesting the 
cysts of the parasite. Many patients remain symtomless. Diagnosis is by finding 
the cysts in the stools. Drugs used to treat the infection include metronidazole 
and mepacrine. 
LARVA MIGRANS. 
In this condition larvae of nematodes enter the human subject and although 
the worm may develop no further, the subject sometimes experiences a wide range 
of clinical symptoms. Skin lesions may be produced by the larvae of Ancylostorna 
braziliensis or Strongyloides stercoralis. As there is usually no associated 
eosinophil ia, the diagnosis is often made on clinical grounds. In treatment local 
freezing (ethyl chloride) may suffice. Thiabendzole has been used for strongyloides 
infections. Sometimes the larval forms of nematodes inhabit the viscera and produce 
severe signs and symptoms. Thus Toxocara canis and T. cati may be involved. 
A high eosinophilia can be present, along with hepatomegaly, fever and respiratory 
syndromes (cough and asthma). Sometimes retinal lesions are to t.e seen and invest-
igations indicate hypergammaglobulinemia. Diagnosis is by finding the larv~e in 
biopsy samples (e.g. liver). Diethylcarbamazine and thiabendazole have been 
tried in the treatment of the condition. 
LASSA FEVER. 
This is virus infection (probably originating in an animal reservoir) and was 
first noted in Nigeria. Clinical features include hemorrhagic fever, vomiting, 
diarrhea and abdominal pain, cough, chest pain, renal failure, myocarditis, and 
encephalopathy. It carries a high fatality rate. Although rare it constitutes 
a real hazard as far as "imported" tropical disease goes and strict precautions 
and isolation must be observed for suspected cases. 
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LEISHMANIASIS. 
A group of disease·due to infection with protoza of the genus Leishmania, 
transmitted.to humans by sandflies. 
Visceral Leishmaniasis (Kala azar). 
This is associated with L. donovani and found in India, tropical Africa and 
parts of the Middle-east. The parasite .is seen in the reticulo-endothelial system 
and a leucopenia is sorr:etimes present. The incubati.on period is long (up to 
several years) and clinical features include splenomegaly, anemia, lymphadenopathy 
and reversal in the A/G ratiO. Some subjects develop a post Kala azardennal skin 
lesion. Diagnosis is by finding the Leishman-Donovan bodies in marrow samples 
or lymph node biopsy or liver samples. Skin tests and fluorescent antibody tech-
niques are also used. Culture methods are available as well. Drugs used to treat 
the condition include Sodium Stibogluconate, Meglumine antimionate and Peritamidine 
isethionate. 
Cutaneous Leishmaniasis. (Oriental Sore) 
This is caused by L. tropica and the incubation period ranges from several 
weeks to several years. The nodular lesions (usually face or limbs) may lead 
to ulcers. There is no systemic involvement· and diagnosis is confirmed by finding 
the parasite in samples taken from the edge of the ulcer·: Drugs used to treat the 




This is present in South America and is caused by·L. braziliensis. Different 
types of the disease are recognised and lesions involve the face or limbs. Diagnosis. 
is by finding the parasite in aspiration samples of the lesion or in biopsy samples. 
Intradennal tests are also available. Treatment is similar to that of oriental sore. 
LEPROSY. 
This disease has a wide distribution in the globe, but is most conunon in 
tropical areas. It is caused by M:leprae. The incubation period is long, from 1-





This spectrum of different forms represents the subject's immune respone to 
the disease. 
If resistance is' low, the lepromatous form is seen, and many body tissues are 
involved (e.g. nerves, skin, reticulo-endothelial system, testes, nose and eyes). 
The tuberculoid form is seen where.resistance is high. Nerves are involved, 
becoming thickened and anesthesia or muscle weakness develop. In dimorphous infect-
ions the features are related to the subject's resistance, which lies between the 
first two types mentioned. Indeterminate leprosy is seen in these who give a 
clinical picture which may develop into the other three types or else clear up. 
The disease can produce a vast range of clinical features including; 
Lepromatous leprosy-Macules, papules or nodules (usually on face or limbs). 
Destruction of nasal cartilage, ulceration of the legs and ichthyosis. Thickening 
of the peripheral nerves (great auricular, ulnar and lateral popliteal). 
Sensory impairment, muscle palsies and claw hand. Absence of corneal reflex. 
Atrophy of digits. Eye changes (keratitis, iri~is and opacities) Atrophy of bones. 
Atrophy of the testes. Renal damage (nephritis and amyloidosis). 
Tuberculoid leprosy. 
Dermal or neural symptoms are present. When nerves ar_e involved, pain loss of 
sensation, paraesthesiae or muscle weakness may appear. Cranial nerves are 
sometimes -involved. Dermal lesions are usually single (plaque) and local nerves 
can usually be palpated when thickened. Skin lesions are erythematous, scaly 
with well defined edges, and there is impairment of hair growth over the lesion. -
Dimorphous leprosy. 
This is probably the corrunonest form of the disease and has features which lie 
between the previous two forms. There may be thickening of the nerves with rr.uscle 
paralysis and anesthesia of the skin. Skin lesions are more numerous (macules, 
punched-out lesions and nodules). 
Indeterminate leprosy. 
Seen in children and several hypopigmented·macules and slight anesthesia may 
be presenL The.disease may heal or develop into one of the other forms. 
DIAGNOSIS. 
1. Skin smears. -
2. Nasal -scrapings. 
3. ·Biopsy of nerves. 
4. Biopsy of skin. 
5. Histamine test. 
6. Lepromin test. 
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The history might raise the possibility of the disease being present and in 
carrying out a physical examination loss of sensation should be looked for. 
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Thickened nerves can be felt on palpation. Biopsy of the skin is useful for class-
ifying the disease. In the differential diagnosis syphilis, yaws, fungal infections, 
leishmaniasis, filariasis and skin conditions such as lichen planus must all be 
considered. The lepromin test is non-specific and is used more for classifying 
the disease rather thatn diagnosis. False positive tests for syphilis may be 
obtained in leprosy and some tests for auto-irrmune conditions may yield a false 
positive. Several reactional syndromes have been described in leprosy (e.g. Lepra 
reaction and Lucio phenomenon). 
Drugs used to tr<!at the disease include Dapsone, Thiambutosine and Rifampicin. 
Beneral medical and surgical care are ~f importance. 
LYMPHOGRANULOMA VENEREUM. 
This virus is related to the psittacosis-trachoma group of viruses. In males 
the initial primary sore is usually on the penis, but in females the primary 
lesion may pass unobserved. Later the infection involves the regional lymph nodes. 
Later complications include fistulae, strictures and an anorectal syndrome. 
Diagnosis is by demonstrating the virus in a smear from the lesion, lymph node 
··biopsy, Frei skin test and complement fixation test. Sulfonamides and tetracyclines 
have been used to treat the infection. Sometimes surgical proceedures are indicated. 
MALARIA-please see earlier notes on this infection. 
MY IASIS. 
This denotes a group of conditions due to an infection with the larvae of 
various flies (e.g. Cordylobia anthropophaga or the Tumbu fly). The larvae are 
capable of invading open wounds, the intestines, eyes or ears. Treatment involves 
removal of the larvae and symptomatic measures. 
PARAGONIMIASIS. 
This is due to the trematode P.westermani in such areas as Korea, China Japan 
and the Philippines. Infection is ·usually by humans eating raw crabs. The adult 
worm lives in the lungs and other tissues. Clinical features include fever, cough,. 
hemoptysis, and a chest X-ray films may resemble Tb. Occasionally the C.N.S. is 
in.valved. To make the diagnosis the eggs of the parasite should be sought in the 
sputum and stools. Intradermal and complement fixation tests are available. Often 
there is a moderate eosinophilia. Bithionol is the drug used for treatment, but 









This infection represents one of the most significant risks of "imported" 
disease, and the physician should always keep this disease in mind. 
TRYPANOSOMIASIS. 
AFRICAN TRYPANOSOMIASIS.-This parasite is transmitted to man by the bite of infected 
tsetse flies. Two strains of trypanosomes are involved in man, T.gambiense and T. 
rhodesiense, and in the main these two parasites produce a similar clinical 
picture, but T. rhodesiense is associated with earlier involvement of the C.N.S. 
and is more difficult to treat. The disease is seen in many parts of- tropical 
Africa. The parasite occurs in the blood, lymphatic system and C.N.S. The in-
cubation period ranges from several weeks to several years and early"clinical feat-
ures include fever, rashes and areas of transient edema. Lymphadenopathy may be 
seen and as the C.N.S. becomes involved headache, drowsiness and personality changes 
can.be observed. Speech difficulties, tremors and muscle weakness are also seen 
when the nervous system is involved. Diagnosis is by finding the parasite in blood 
films or in a fresh aspirate sample obtained from affected lymph nodes. In later 
stages of the disease the trypanosomes may be detected in the C.S.F., which then 
also shows an increase in cells and protein content. Serological tests are avail-
able as well. Pentamidine and Suramin have been used to treat the disease, and 
Pentamidine has been used for chemoprophylaxis • 
. AMERICAN TRYPANOSOMIASIS. (Chagas's Disease). 
The parasite is transmitted to man by the bite of a reduviid bug and is present 
in South and Central America. Following the initial infection there may be swelling 
of the local lymph nodes and sometimes unilateral swelling of the tissues around 
_the eye (Romana's sign). Other clinical features include pyrexia, tachycardia, 
enlargement of the liver and spleen and cardiac complications (arrhythmias and 
cardiomyopathy). Diagnosis is by finding T. cruzi in the blood or the leishmanoid 
forms in the tissues (e.g. muscles). Blood cultures, xenodiagnosis and complement 
fixation tests have also been used. Treatment.is unsatisfactory, but primaquine 
and Bayer 2502 have been used. 
YAWS. (Framboesia). 
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This infection is due to treponema pertenue and is a disease which mainly affects 
the indigene rather than the visitor. Primary, secondary and tertiary stages are 
recognised. Granulomatous lesions may involve many tissues. The disease should 
be differentiated from syphilis. Penicillin is effective in treating the disease. 
CHAPTER 8 
THE CHEMOTHERAPY OF SOME PARASITIC DISEASES. 
Many of the drugs used to treat parasitic infections have potential adverse 
reactions and in-all cases the "benefit to-risk" ratio should be assessed. 
Examples of toxic drugs include emetine, niridazole, antimony compounds and-.the 
arsenicals. Sometimes the death of a parasite is associated with-a violent. 
"allergic" reaction in the host and steroids or antihistamines may be needed (e.g. 
in schistosomiasis or onchocerciasis). Antiparasitic drugs should not be used in 
pregnancy unless they are essential. 
BEPHENIUM -HYDROXYNAPHTHOATE. 
This is used in ancylostomiasis ·and is usually well tolerated. Adverse re_. 
actions include nausea, vomiting and diarrhea. 
DOSE (Adult). 
Necator americanus-5GM. b.i.d. for three days. This is taken in water 2 
hours before food. Given orally • 
. A.r:i.s;yloc;t0ma duodena le- 5 GM. b. i.d. for one day. 
(N.B. When re-checking the feces for the presence of any eggs of the worm, at 
least 3 weeks.should oe allowed to lapse after treatment). 
BITHIONOL. 
The toxic effects include vomiting, diarrhea, skin rashes and albuminuria. 
DOSE (Adult). 
Paragonimus westermani infections-30-50 mg./kg. on alternate days for 10-15 
doses, given orally: 
Similar doses have been used for clonorchis infections. 
CHLOROQUINE. 
This is widely used as an antimalarial. It is effective against the asexual 
erythrocytic forms of the parasite. -However it does not prevent relapses in 
subjects with P.vivax and P.malariae infections as it is not effective against 
the exo-erythrocytic forms of the-parasite. 
Indications. To suppress attacks of malaria due to P.vivax, P.malariae and P. 
falciparum (where the parasite is not resistant). It is also used in the therapy· 





Contraindications. It should not be given to those with a history of hypersen-
sitivity to the 4-aminoquinolines or subjects with significant ocular pathology 
(especially retinal or visual field changes). 
Precautions. Some strains of P.falciparumare resistant to the drug. When the 
compound is given for long periods of time regular ophthalmological examinations 
should be carried out. If any visual signs or symptoms are noted the drug must 
be discontinued, and the subject followed up. The drug may exacerbate porphyria 
or psoriasis. The drug should be.used with caution in those with hepatic disease 
or G-6-PD deficiency. 
ADVERSE EFFECTS. 
These include headache, vomiting, pruritus, G-1 upsets, convulsions, hall-
ucinati.ons, neuromyopathy and blood dyscrasias. Eye changes represent the most 
significant potential risk. Blurring of vision or difficulty in focussing may 
be seen but these are usually reversible and disappear on discontinuing the drug. 
Other more serious changes have been noted in association with long term therapy 
including corneal changes (edema and deposits) and retinal changes (including 
optic atrophy). 
DOSAGE. 
For use as an antimalarial please see notes on malaria. 
Amebic Hepatic Abscess- Chloroquine-phosphate-1 GM. daily is given orally for 
_two days, then 500 mg. daily is given for 21 days. 
Clonorchts sinensis infections-Chloroquine phosphate-250 mg. t.i.d. is given orally 
for 6 weeks. 
Paragonimus westermani infections-Chloroquine phosphate is given orally-250 mg. 
t.i.d. for 6 weeks. 
DAPSONE. 
This.drug has been used in leprosy and malaria. Toxic effects include fever, 
anemia, ski_n rashes, psychoses and _methemoglobinemia. Subjects with G-6-PD 
deficiency may develop a hemolytic anemia. 
Dose-Leprosy-doses of 25 mg.-100 mg./week have been used. 
-Malaria-In chemoprophylaxis daily doses of dapsone 25 mg. have been given 
in association with weekly doses of chloroquine (300 -mg. base) and 45 mg. _ 
primaquine (base). 
The drug has also b~en used to treat acute chloroquine-resistant P.falciparum 
malaria (25 mg. orally, daily for 28 days) 
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DEHY DROEMETI NE. 
This is a toxic drug with similary properties to emetine. The main toxic effects 
relate to the heart (arrhythmias) and patients receiving the drug should have 
cardiac monitoring. 
Dose 
Amebiasis(Severe intestinal disease) - Dehydroemetine-1.0-1.5 mg./kg .. daily 
given I.M. ·or S.C. for 5 days. 
Amebic Hepatic Abscess 
The drug has-also been given 
resinate). It has also been used 
schistosomiasis. 
DIETHYLGARBAMAZINE. 
- Dosage as above. 
orally (as dehydroemetine bismuth iodide or the 
in the therapy of cutaneous leishmaniasis and 
This piperazine derivative is used to treat filariasi~ and pulmonary tropical· 
eosinophilia. Toxic effects include vomiting and dizziness. The death of the· 
microfilariae may be-dssociated with severe allergic reactions-and antihistamines 
and steroids have been used to cover these·adverse effects.· The drug must be used 
with great care in onchocerciasis. It may produce itching, lymph node enlargement, 
fever or a rash. If a patient has eye involvement with onchocerciasis then steroids 
should be given several days before therapy is initiated and during treatment. 
Both cortisone drops and systemic steroids have been used to prevent allergic reac-





Tropical Pulmonary Eosinophilia. 
For all the.above infections, Diethylcarbamazine citrate (Hetrazan) is given 
orally at a dose of 2 mg./kg. t. i
0
.d. for 14 days. 
Onchocerca volvulus (River Blindne'ss) 
Diethylcarbamazine citrate is given orally-(Adults). 
25 mg. daily for 3 days. 
50 mg. daily for 5 days. 
·-·--Hl'O mg. daily for 3 days . 
. , .. 150--::ig. daily for 12 days. 
In order to kill the adult worm the above should be followed by a course of 
Suramin (see notes on the drug) which is very toxic. In adults a test dose of 
100 mg. of Suramin is given intravenously. If this is tolerated then I.O gm. of 
the drug is given intravenously once a week for 5 weeks . 
. DIIODOHYDROXYQUIN. 
This have been used to treat asymptomatic cyst "passers" of Entameba 
histolytica. Toxic effects include skin rashes, nausea and thyroid enlargement. 
Optic neuritis has also been associated with use of the drug. 
Dose 1Adults). 
650 mg. t.i.d. for·20 days given orally. 
DILOXANIDE FUROATE. 
This is a well tolerated compound used to treat asymptomatic intestinal 
amebic infections and mild amebic dysentery. 
Dose. (Adults) 
0.5 Gm. t.i.d. for 10 days. 
EMETINE. 
This toxic drug is used to treat amebiasis. Adverse effects include cardiac 
damage, hepatic and renal damage. Local reactions may be seen also (including 
myositis). Some 50% of subjects show E.C.G. changes. (flattening or inversion 
of T wave and prolonged QT interval ).Vomiting and diarrhea may be produced by the 
drug. The drug must not be given to those with cardiac, renal or hepatic 
dysfunction and should be avoided in pregnancy. 
DOSE (Adults). 
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It is given by the S.C. or I.M. route (maximum daily dose is 65 mg.) lmg/kg./ 
B.W. For normal adults a daily dose of 65 mg. is given for 10 days or less. The 
patient should have bed rest and cardiac monitoring is essential. Given by injection 
the drug has no effect on intestinal luminal infections and emetine bismuth iodide 
tablets have been used for luminal infections (Adults-oral dose of 200 mg./day for 
l 0 days). 
MEBENDAZOLE. (Vermox) 
Because of limited clinical experience this drug should not be used in children 
under two years of age, and it is contraindicated in pregnancy. It has been used to 
treat Trichuris, Ascaris, Hookworm and Pinworm infections. Adverse effects include 
abdominal pain and diarrhea~ 
Dose.(Children and adults). 
(For trichuriasis, ascariasis and hookworm. infections)-Mebendazole-100 mg. tablet-I 




As-an antimal~rial mepacrine has a_ similar action to chloroquine and quinine, 
but it now it is very little used as an antimalarial. It has a place in the therapy 
of tapeworm infections and giardiasis. Adverse effects include a yellow staining 
of the skin and urine. Headaches, vomiting, skin rashes and mental changes have 
also been reported. It should not be given with 8-aminoquinoline drugs as there is 
increased toxicity. 
Dose 
As a teniacide. 
Mepacrine hydrochloride (Adult dose) given orally. Patient is put on a bland 
non-fat diet the day before. A saline purge is given, and the subject should fast 
from the ·previous evening. A total of 600-800 mg.-of the drug is given. (200 mg. 
at 10 minute intervals). Sodium bicarbonate should be given with each dose to 
prevent vomiting.- Another purge is given two hours after the last dose, and if 
possible the scolex of the worm should be indentified. It should not be used for 
T. Solium infections. {Risk of cysticercosis). 
GIARDIASIS. 
Mepacrine hydrochloride-100 mg. is given orally t.i.d. for 7 days. {Adults). 
- MET RON IDAZOLE. 
This is effective in arnebic dysentery and amebic hepatic abscess, and has been 
used to treat giardiasis. Adverse reactions include headache, vomiting, skin 
rashes and leucopenia. It darkens the urine and can produce a bitter taste in the 
mouth. 
Dose (Adults). 
(N.B. Alcohol is contraindicated several days before, during and several days 
after therapy). 
Arnebiasis. 
Asymptomatic cyst passer-Metronidazole 750 mg. t.i.d. orally for 7-10 days. 
Moderate intestinal disease-Metronidazole 750 mg. t.i.d. orally for 7-10 days. 
Severe intestinal disease-Metronidazole 750 mg. t.i.d. orally for 7~10 days. 
Hepatic Abscess-Metronidazole 750 mg. t.i.d. orally for 7-10 days. 
(N.B. Cases of amebi.c hepatic abscess have been reported when the drug has been 
used as the sole therapeutic agent to treat intestinal amebic infections and. 
the drug has been given in association with other compounds in an effort to prevent 





Metronidazole-500 mg. t.i.d. orally for 5-10 days. 
NICLOSAMIDE (Yomesan). 




Niclosamide-2 gm. is chewed thoroughly and taken as a single dose after a· light 
meal. (N.B. with T.solium infections the drug breaks up.the segments of the wonn 
and the release of the eggs may cause cysticercosis). 
NIRIDAZOLE. (Ambil har): 
This compound is effective in schistosomiasis, the best results being obtained 
in S. hematobium infections. The drug is metabolized rapidly in the liver and 
its metatabolites color the urine dark brown. Adverse effects include vomiting, 
headache, skin rashes, hemolyt.ic anemia and C.N.S. changes (convulsions, psychoses 
and confusion). C.N.S. effects may be marked when the patient has hepatic 
dysfunction, and are due to the unmetabolized drug. Thus the drug must be given 
with caution to those with impaired hepatic function. Likewise it must be 
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·administered with caution to subjects with shJ1_1ificant renal disease. E.C.G. changes 
which may be observed when the compound is given include flattening of the T 
waves and S-T depression. 
Dose·. 
Schistosoma hematobium. 
Niridazole-given orally-25 mg./kg. of body weight, daily. (maximum I. 5 gm.) 
for 5-7 days. 
A similar dosage can be used for S.mansoni infection.s, but some prefer to use 
stibophen for that infection. Antimonyl potassium tartrate is given for .S. 
japonicum infections. 
N.B. Because of the toxicity of the drug, patients on the drug must be carefully 
observed. 
PALUDRINE (Paludrine/Chloroguanide)-see notes on. chemotherapy of malaria. 
PENTAMIDINE. 
This is used in early trypanosomiasis (Gambiense/Rhodesiense). It is of no use 
if .the C.N.S. is involved. It has also been ·used in.visceral leishmaniasis and in 
the prophylaxis of trypanosomiasis. Adverse effects include_.bypotension, hypoglycemia 
and vomiting. 
Dose. 
T.gambiense (hemolytic stage)-Pentamidine 4 mg./kg. of body weight I.M. daily 
for 10 days. A similar dose has been given for T. rhodesiense (hemolytic stage), 
but Suramin is preferable as a first choice. 
58. 
(N.B. for T.rhodesiense and T.gambiense infectio·ns with C.N.S. involvement Melarsoprol 
is used. The dose is 2-3.6. mg./kg. of body weight I.V. daily for 3 doses. After 
one week 3.6 mg. is given I.V. daily for three doses. 
Treatment may be repeated after 12-21 days. 
Adverse effects include cardiac damage, hypertension, albuminuria, ·encephalopathy, 
shock and peripheral neuropathy). 
Chemoprophylaxis (African trypanosomiasis) 
This may be considered for subject at ''high" risk. 
Pentamidine is given-4mg./kg. of body weight given I.M. every 3-6 months. 
PIPERAZINE CITRATE. 
This compound is used to treat ascariasis and enterobiasis (pinworm). 
Adverse effects include vomiting and headache, and the drug should be used with 
caution in children as larger doses can produce C.N.S. changes (tremors and vertigo}. 
It should not be administered to those with a history of ep11e~sy or renal impairment. 
Dose. 
Ascariasis. 
Up to 30 lb. of body weight.-I.O Gm. daily. 
30 - 50 lb. -2.0 Gm. daily. 
50 - l 00 lb. 
Over 100 lb. 
II -3.0 Gm. daily. 
-3.5 Gm. daily. 
The drug is given for 2 days. Both tablets and syrup are available. 
Enterobiasis. 
Up to 15 lb. of body weight.-250 mg. daily. 
15-30 Ib. -500 mg. daily. 
30-60 lb. 
Over 60 lb. 
" - l 000 mg. daily. 
-2000 mg. daily. 
The drug is given orally for 7 days, withheld for 7 days then given for another 7 
days. 
PRIMAQUINE PHOSPHATE.- see notes on-malaria. 
PYRANTEL PAMOATE. (Combantrin) 
This preparation is indicated for the treatment of pfnworm, hookworm and ascaris. 




Dose.-see notes on "worms" 
PYRIMETHAMINE-see notes on malaria. 
PYRVINIUM PAMOATE. 
A useful drug for the treatment of pinworm, but has the disadvantage of staining 
the stools red. Usually well tolerated. 
Dose. 
50 mg/ 22 Ib. of body weight, given .as a single dose. 
QUININE. 
This toxic drug has a place in the therapy of malaria and its toxic effects include 
visual changes, cinchonism, hypotension and cardiac arrhythmias. 
For .dosage see notes on malaria. 
SULFONAMIDES. 
Sulfonamides have been used for.the.chemoprophylaxis of malaria, but in view 
of the potential risks of long term administration of these.compounds, they are not 
reco11U11ended for routine prophylaxis. However they have a place in the treatment 
of chloroquine-resistant malaria. (see n.otes on malaria). 
SU RAMIN. 
This is used in the therapy of trypanosomiasis and onchocerciasis. It is very 
toxic (adverse reactions include shock, neuritis, albuminuria, .hepatic damage and 
photophobia). It should be noted that the drug is not effective when the C.N.S. is 
involved in trypanosomjasis. 
Dose. 
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Trypanosomiasis (T.gambesiense/T.rhodesiense)-100-200 mg. test dose I.V. then 1.0 Gm. 
IV cin days l,3,7,14 and 21. 
It is not effective in South American trypancisomiasis. 
(In onchocerciasis suramin 100-200 mg. test .dose IV, then l Gm. IV at weekly 
intervals for 5 weeks is given in association with a course of diethylcarbamazine). 
TETRACYCLINES. 
Tetracyclines have been used to treat amebic infections (always in association with 
other drugs), balantidiasis and in addition they have some antimalarial effects. 
THIABENDAZOLE. {Mintezol) 
This drug is a broad spectrum.antihelminthic, but used mainly in trichuris trichuria 
infections (though mebendazole is more effective) and cutanecu·s· larva migrans. It 
has also been used in trichinosis and hookworm infections. Adverse effects include 
dizziness, headache; vomiting, skin rashes and leucopenia. 
Dose.· 
Trichuris trichuria-25 mg./kg. of body weight b.i.d. for 2 days. 
Trichinosis. -25 mg./kg. of body weight b.i.d. until symptoms.are reduced 
or toxic effects are present. 
Hookwor.m infections-25 mg./kg. of body weight for 2 days. B.I.D. 
The drug is given orally. 
GENERAL CONSIDERATIONS. 
l. When ascaris is present in association with other intestinal helminths, ascaris 
should always be treated first. 
2. Where possible follow up tests should be done after treatment of any parasitic 
disease. Sometimes these should be done for many months after therapy. (e.g. in 
amebiasis). 
3. Where the:drugs concerned are highly toxic, the physician must assess the 
benefit to risk ratio for each individual case. 
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CHAPTER 9 . 
. SOME CLINICAL CONSIDERATIONS. 
A. PARASITE NEUROSIS. 
One point to stress is that some subjects deve°lop a significant fear of parasites 
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on their return from the tropics, and the physician must be careful not to encourage 
such. a complex. This is most often seen in individuals who have had. amebic dysentery 
or who have heard of the disease. Years after returning from the tropics they 
attribute any symptoms, especially those relating to the G-I tract, to a possible 
amebic infections, and in spite of negative tests they travel from physician to 
physician in an effort to identify a non-existent parasite. 
B. CO-EXISTENT DISEASE. 
The physician should be careful not to ascribe all the patient's symtoms to a 
particular parasite, and care should be taken not to overlook any associated organic 
disease. Thus one student, in his mid-twenties was seen on account of vague 
abdominal symptoms. The history r.evealed that two years previously he have been in 
South America. The subject mentioned that previous stool examinations had been 
negative, but these had been preserved samples. Examination of a fresh stool sample 
showed evidence of a heavy giardia infection. This responded to a course of 
metronidazole, and the subject had no further abdominal symptoms. However after 
severa1 months his original symptoms re-appeared. Further review of his case 
revealed a history suggestive.of a duodenal ulcer, and he responded well to a suit-
able diet and antacids. Further stool samples were negative. 
C. MULTIPLE PARASITIC INFECTIONS ARE NOT RARE. 
A 25 year old man, originally from Pakistan, but who had been in Canada for over 
a year, presented with a complaint of severe headache. His friends told him that 
he had "flu'; but increasing doses of ana.lgesics failed to ameliorate his symptoms. 
Peripheral blood films revealed the presence of P.vivax,_and his symtoms soon re-
sponded to a course of chloroquine. As he intended to stay in Canada a course of 
primaquine was then given to eradicate his malaria. His blood pic:ture soon returned 
to normal. However a routine W.B.C. several weeks later revealed an eosinophilia 
of over 25%-a finding which had· not been present earlier. Examination of his stools 
revealed the presence of a hookworm infection which responded to pyrantel pamoate. 
Thus even when one major parasite is found, one should always be on the lookout for 
other. infections. Patients with amebiasis in association with other intestinal 
infections are by no means rare. 
D. PROLONGED PURSUIT FOR PARASITES. 
A young student from West Africa complained of painless hematuria. An obvious 
parasite to eliminate was S.hematobium, but repeated urine tests failed to reveal 
the eggs of the worm. An I.V;P. and blood work revealed no abnormalities. It 
was only on cystoscopy that the diagnosis was confirmed and he made a good recovery 
on niridazole. An.other: young male gave a history of a lengthy stay in India and 
Nepal, and on his return to Canada giardia had been found in his stools. He 
had _been given a course of metronidazol e and appeared we 11. However one year later 
he suffered from attacks of vague lower abdominal pain and some diarrhea. Repeated 
-investigations and stool examination revealed no abnormalities. His symptoms per-
sisted for many months and he was admitted to hospital for observation. Again 
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fresh stool tests were negative. Months later fresh stool tests revealed the 
presence of giardia, and he was given. a further course of metronidazole. He then 
remained symptom-free. Sometimes amebic infections and giardiasis are only detected 
many yea!"s after the original exposure, and one negative stool test_ does not mean 
too much. 
E. "WE STOPPED THE MALARIA PILLS TOO EARLY, DOCTOR". 
Many families return from the tropics and readily admit that they took their 
antimalarials incorrectly er stopped them too early. In most cases it is best to 
warn them tha_t if they have an unexplained fever or malaise after their return. 
then the possibility of malaria must always be kept in mind and blood films must 
be done. Once they have been away from the tropics for several months there 
is little point in them taking further antimalarials. 
F. ANEMIA IN CHILDREN RETURNING FROM THE TROPICS. 
A mild degree of iron-deficiency type of anemia seems to be common in young infants 
returning from the tropics. In all cases it is essential to rule out the presence 
of any parasites or other causes {blood dyscrasias etc) but when this has been 
done many-of these subjects have an unexplained anemia. Any persistent eosinophilia 
would lead one to continue to search for a possible parasite. In most of the 
cases the anemia gradually improves when the child is away from the tropics and pre-
sumably dietary causes play a role. 
G .. UNDE VENIS?-THE RIGHT TIME BUT THE WRONG DRUG. 
A young Malaysian student lived in Europe for some 5 years. - Following this she 
returned home for a five-week vacation. No antimalarials were taken. She developed 
episodes of fever but a search for malaria was negative. Prior to leaving for N. 
America malaria was eventually detected and she was given a course of Quinine. 
In N. America she continued to have episodes of fever and Plasmodium vivax was 
seen on .blood film examination. A short course of Chloroquine, followed by 
Primaquine resulted in a cure. Points to remember are that when an indigene from 
a malarious area spends several years out of the tropics, there is some loss of 
immunity to malaria and antimalarials may be needed when they eventually return 
home. Also for P.vivax infections, Primaquine.is needed in order to effect a 
radical cure. 
H. PARASITES IN GENERAL PRACTICE? 
Is it worthwhile looking for parasites in a general practice unit? The 
. answer is an emphatic yes, especially for the physician with a good nu~ber of 
peripatetic subjects. Thus in one general practice unit 60 subjects with a history 
of travel in the tropics were investigated, and 20 of these had positive findings 
(including entameba histolytica, giadiasis, hookworm, ascaris, schistosomiasis, 
tapeworm and trichuris). ·As these parasites constitute a threat to the individual 







SMl\l.L. POX - ON RETURN 
VARIOLE - AU RETOUil 
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. ~MER!CAN SAMOA- SAMOA AMli!RiCAIN 
ANGOLA 




BAHRAIN - BAHRE.IN 
BArlGLADESH 
EMlO.:.oos - BARBAOE 
SE·.G!UM - BELGIQUE 
EE:"'MUOA - BERMUDES 
BOLIVIA - BOLIVIE 
BOTSi'U,NA 
eAAZll.- BR~Sll. 
bRITl:iH HONCiJRAS - HONDURAS BRITANNIOUE 
ER1T1S~1 !:l'")LOMOI,, iSLANDS PROTECTORATE 
PROT<:'.;TOAAT ORITANNIQIJE DES ILES SALOMON 
ERUNCI - BRUNEi 
6ULCAAiA - BULGARIE 
BURMA - B:RMANIE" 
BURUNDI 
CAMEROON - CAMEAOUN 
CANADA 
. CANAL ZO:-IE - ZONE DU CANAL 
CAPE VEAUE 15LANDS - ILES OU CAP VERT 
CAYMAN ISLANDS 
.. 
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SMALL POX - ON RETURN 
VARI OLE - A.U AETOUR 
SMALL POX - REQUIRED TO VISIT 




CHAO - TCHAO .. R R 
CHILE - CHILI " 
CHINA. PEOPte·s REPUBLIC OF .. R CHINE, R£PUBLIOUE POPULAIRE OE 
CHINA !TAIWAN) - CHINE !TAIWAN) .. 
CHRISTMAS ISLAND - (INDIAN OCEAN::- OC~AN INOIEN) 
COLOMBIA - COLOMBIE .. R 
COMORO ARCHIPELAGO - tERRITOIAE DES COWORES .. 
CONGO .. • 
COOK' ISLANDS 
COSTA RICA ... R 
CUBA 
CYPRUS - CHYPRE 
CZECHOS\.OVAKIA - TCH£CCSL0VAOUlE 
OAHO~E:Y " R .. DENMARI( - OANEMARK 
DOMINICA - OQt.&INIOUE 
DOMINICAN REPUBLIC - Rf PUBLIOUE OOMINICAINE 
ECUADOR - tOUATEUR, " EGYPT - tGVPTE " El SALVADOR 
EQUATORIAL GUINEA - GUINh [OUATORIALE .. R·· 
ETHIOPIA - tTHIOP\f .. " " FALKLAND IMALVINASI ISLANDS .. 
FAROE ISLANDS - llES F~RO~ 
FIJl-FIDJI 
FINLAND - flNLANOE 
FRANCE 
FRENCH POLYNESIA - POLYNESIE FRAN<;AISE • 
FRENCH i'ERRITOAY OF THE AFARS A.NO THE ISSAS -
" TERRITO IRE fRANf;AIS OES AfAAS ET DES ISSAS 
GABON " " GAMBIA - GAMBIE " 
GERMANY. DEMOCRATIC REPUBLIC Of 
ALLEMAGNE. RE.PUBLIOUE DEMOCRATIOUE ALLEMANDE. 
GERMANY, FEDERAL REPUBLIC OF 
ALLEMAGNE. R{PUBLIOUE FfDEffALE D'ALLEMAGNE 
0 
GHANA " R ·R 
YELLOW FEVER 
r'I EVRE JAUNE 
CHOLERA 
CHOLERA 
SMA.l.L POX - CN RETURN 
VARIOLf - AU RETOUR 
SMAl.L POk - REOUIRED TO VISIT 





GILBERT & El'-ICE ISU\NOS 
Gl'1EE'CE - C.A~CE 
GREENLAND - UROENLAND 
G~ENA.OA - GRENADE 
GUAM 
GUATEMALA 
'GUERNSEY, ALDERNEY ANO SARl(-
GUEANESEY, ALDERNEY ET SARI( 
GUINEA - GU!Nl!E 




KU~G.£.AY - HONGRIE 
!CELANO - ISL.ANOE 
11mt,\ - INOE 
INOCNE:SIA - INOONl!SIE 
IMAN 
IRAC - !RAK 
IRELANO - l~LANOE 
ISLE OF "'AN - ILE DE MAN 
ISRA?:L- !SRA£\.. 
ITAL'\'- iTALIE 
IVORY COA.ST - COTE 0·1vo1RE 
Jtt,"'4.\ICA - JAMAiOUE 
.:APAN - JAPON 
JERSEY 
JORDAN - JOFsOANIE 
r:ENYA 
KHMER REPUBLIC - REPIJBLIOUE KHMERE 
KUWAIT - KOWEiT 
LAOS 
LEBA/liO~ - LIBAN 
LESOTHO 
LIBERIA - LIBERIA 
LIBYAN ARAB REPUBLIC -
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SMALL POX - ON RETURN 
VARIOlE - ,\U RETOUA 
SMALL POX - REQUIRED TO VISIT 





MACAO * UADA.GASCAR * MALAWI • R 
MALAYSIA - MALAISIE * R MALDIVES • 
MALI * R * MALTA-MALTE 
MAUAITA,.,IA- Mr.UAITANIE * * 
MAURmus - MAU~ICE .. 
MEXICO - MEXICUE 
MONACO 
MQNGOLIA - MCNGOLIE • 
MONTSERRAT • 
MOROCCO - MAAOC 
MOZAMBIQUE * R 
NA!.l!BIA - NAMIBIE • 
NAURU • 
NEPAL - N~PAL • R 
NETHERLANDS - PAYS-BAS 
NETHERLANDS ANTILLES-ANTILLES N£ERLANDAISES 
NEW CALEDONIA ANO DEPENDENCIES - • NOUVELLE·CALE:OONIE ET D£PENDANCES 
NEW HEBRIDES- NOUVELLES·H£BRIDES • 
NEW ZEALAND- NOUVELtE·Zi:LAHDE 
NICARAGUA • 
NIGER .. R • 
NIGERIA- N!G£RIA * R • 
NORWAY - NOAVEGE 
O~AN • 
PACIFIC ISLANDS. TRUST TERRllORY OF THE USA -
ILES OU PACIFICUE (TERRITOIRE SOUS TUTELL£ DES USA) 
PAKISTAN • R 
PANAMA * 
PA.PUA AND NEW GUINEA. TERRITORY OF AUSTRA1.IA- • TEAR1TOIRE AUSTAALIEN OE PAPUA El NOUVELLE·GUIN£E 
PARAGUAY * R 
PEOPLE'S DEMOCRATIC REPUBLIC OF YEMEN 





SMIAU POX - OM RETURN 
VARI OLE - A.U RETOUR 
SUALL POX - REQUIREC" TO VISIT 
VARI OLE - EXIG~E POUR VISITER 
. COUNTRY- PAYS 
• REQUIREC/EX!GE:E 
R RECOMMENDED/A'ECOUMANDl!:E 
PERU- Pt.AOU • R 
PHILIPPiNES .. R 
PITCAIRN ISLAND 
POLAND - PQLOG!l:E 
PORTUGAL 
PORTUGUESE GUINEA- GUIN~E POFtTUGAISE • • 
PORTUGUESE TIMOR - TIMOR PORTUGAIS • • 
PUERTO RICO - PORTO RICO 
QATAR. • 
REPUBLIC _OF KOREA- REPUBLIQUE OE COR£E .. 
ROMANIA- ROUMANIE 
RWANDA • 
RYUKYU ISLANDS - ILES RYU·KYU .. 
SAINT HELENA - Si'olf.;TE H~LENE • 
SAINT KlTIS·NE ... lS·ANOUJLLA 
SAINT-CHRISTOPHE ET Nl~ES .ET ANGUILLA 
SAINT LUCIA- SAINTE-LUCIE 
SAINT·PIERRE & MIQUELON 
SAINT VINCENT 
SAO TOME & PRINCIPE • .. 
SAU:>I ARABIA-ARABIE SAOUOITE * .. 
SENEGAL - s£~atGAL • • 
SEYC.rlEi.lES •· 
SIER"E LEON( * R 
SINGAPORE - SINGAPOUR • R 
SOMALIA - SOM"'UE • 
SOUT!i AFi1iCA-AFP.ICUE DU sue • 
SOUTHERN RHOCESIA - RHOOl::SIE DU SUD • R 
SPAIN (EXCEPT CANARY ISLANDS) 
ESPAGNE {EXCEPTE lLES CANARIES) 
CANARY ISLANOS- lLES CANARIES 
S?ANISH SAHARA- SAHARA ESPAGNOL 
SUDAN - SOUOAN .. R 
SUMINAM .. R 
SWAZILAND - SOUAZILAND .. 
SWEDEN - su~DE 
SWITZERLAND - SUISSE 
SYRIAN ARAB REPUBLIC -





SlotALL POX - ON RETURN 
_YARIOLE - AU RETOUR 
SMALl. POX - REOUIRED TO VISIT 




THAILAND - THAiLANOE • R 
TOGO • R • 
TONGA .. 
TRINIDAD AND TOBAGO-TRIN1T£-ET0 TOBAGO 
TRUCIAL SHEIKHDOMS - • CHELKHATS SOUS R£GIME DE TRAIT£ 
TUNISIA - TUNJSIE 
TURKEY- TURCUIE 
UGANDA - OUGANOA • 
UNION OF SOVIET SOCIAL/ST REPUBLICS 
UNION DES R£PUBLIOUES SOCIALISTES sov1£TICUES 
UNITED KINGDOM - ROYAUME·UNI 
UNITED REPUBLIC OF TANZANIA • R R£PUBLIOUE·UNIE DE TANZANIE 
UNITED STATES OF AMERICA- i:.TATS·UNIS O'AM£AIQUE 
UPPER VOLTA-1-JAUTC·YOLTA • R • 
URUGUAY • 
'VENEZUELA • R 
VIET·NAM (REPUBLIC OF)-YIETNAM (RG:PU6LIOUE DU) • R 
VIRGIN ISLANDS (USA) 
ISLES VIEAGES DES 8'ATS·UNIS D'AMERICUE 
WAKE ISL.ANO 
WESTERN SAMOA- SAMOA-OCCIDENTAL • 
YEMEN - Y£MEN • R 
YUGOSLAVIA- YOUGOSLAVIE 
ZAMBIA- ZAMBIE • 
ZAIRE - ZAiRE • R 
Trav!llers are advised that the vaccination requirements of 
coUntries in which they arrive are related to the health conditions 
in the country of departure and to health conditions in the 
countries in which travellars disembark during their journey, 
Les voyageurs sent avartis qua 1411 exigences de vaccination des 
pays d'enuOO sont 1oumises aux conditions sanitaireis du pa'fl · 
d"origine et aux conditions sanltaires existantes dans les pays, 
de s6jour. 
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KATAYAMA SYNDROME 42. 
i LARVA MIGRANS 47, ~-
I LASSA FEVER 47. 
LEISHMANIASIS. 48. 
" LEPROSY 48. 
LIVER ABSCESS 31. 
LIVER FLUKE 41. 
LOEFFLER' S SYNDROME 38. 
LYMPHOGRANULOMA VENEREUM so. 
ARCHU Tropical and travel medec 
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NlCLOSL'1IDE 42, 57. i : 
NIRIDAZOLE 42, 57. 
OVERLANDER SY~'DP.OXE: 36. 
PALUD'.l.:~:E 20. 
PA.~GO!l:W-!US 50. 
PENTA:1!DINE 5 7. 
PINWOR.'fS 43. 
PIPERAZINES 39, 43, 58. 
PRU!AQUU·:E 21~ 23. 
PYRL'iTEL PAMOA'.i'E 39, 58. 
PYRIMETII!-.MINE 21, 23. 
PYRVINIUM PAY.DATE 40, 44, 59. 
P.u.o. 33. 
QUININE 21, 27. 
RONANA'S s:::cx 51. 
SQUSTOSO}!J..ASIS 41. 
SMALLPOX VACCI~IB 6. 
STRONGYWIDES 40. 
TAPEWOR.'1S 42. 
TtlHBENDAZOLE 40, 59. 
TRICHURBSIS 41. 
TRYP ANOSOML.\.SIS 51. 
TYPHOID VACCINE 7. 




YELLOW FEVER V.\CCINE .6. 
